federal grant funding opportunities...mental and substance use disorders prevalence study ..... 8 2....

1

Federal Grant Funding

Opportunities

Updated June 26, 2019

2

Contents Overview of Resources to Help Ohio Communities Combat the Opioid Epidemic .........................................................5

CURRENT FUNDING PROGRAMS THROUGH SAMHSA: .................................................................................................8

1. Mental and Substance Use Disorders Prevalence Study ............................................................................................ 8

2. Mental and Substance Use Disorder Practitioner Data .............................................................................................. 8

3. Tribal Opioid Response Grants.................................................................................................................................... 9

4. Expansion of Practitioner Education ......................................................................................................................... 10

5. Drug-Free Communities (DFC) Support Program - New ........................................................................................... 10

6. Drug-Free Communities (DFC) Support Program – Competing Continuation .......................................................... 11

PAST FUNDING PROGRAMS THROUGH SAMHSA: ...................................................................................................... 12

7. Rural Opioid Technical Assistance Grants ................................................................................................................. 12

8. Provider’s Clinical Support System – Universities Grants ......................................................................................... 12

9. National Evaluation of the Technology Transfer Center Program ............................................................................ 13

10. Transforming Lives Through Supported Employment .......................................................................................... 14

11. First Responders-Comprehensive Addiction and Recovery Act ............................................................................ 15

12. Minority Aids Initiative: Substance Use Disorder Treatment for Racial/Ethnic Minority Populations at High Risk

for HIV/AIDS ...................................................................................................................................................................... 15

13. Building Communities of Recovery ....................................................................................................................... 16

14. National Center of Excellence for Integrated Health Solutions ............................................................................ 17

15. Strategic Prevention Framework – Partnerships for Success ............................................................................... 18

16. Targeted Capacity Expansion: Special Projects ..................................................................................................... 18

17. Provider’s Clinical Support System – Medication Assisted Treatment Grant ....................................................... 19

18. Grants to Expand Substance Abuse Treatment Capacity in Family Drug Courts .................................................. 20

19. Grants to Expand Substance Abuse Treatment Capacity in Adult Treatment Drug Courts and Adult Tribal

Healing to Wellness Courts ............................................................................................................................................... 21

20. Tribal Behavioral Health Grant Program ............................................................................................................... 22

21. Rural Opioids Technical Assistance Grants ........................................................................................................... 22

22. Center of Excellence for Protected Health Information Related to Mental and Substance Use Disorders ......... 23

23. State Opioid Response Grants .............................................................................................................................. 24

24. Prevention Technology Transfer Centers Cooperative Agreements .................................................................... 25

25. Opioid State Targeted Response Technical Assistance ......................................................................................... 26

26. Targeted Capacity Expansion: Medication Assisted Treatment – Prescription Drug and Opioid Addiction ........ 27

CURRENT FUNDING PROGRAMS THROUGH HRSA: .................................................................................................... 28

PAST FUNDING PROGRAMS THROUGH HRSA:.................................................................................................................. 28

27. Rural Communities Opioid Response Program – Assisted Treatment Expansion ................................................ 28

28. Rural Communities Opioid Response Program – Rural Centers of Excellence on Substance Use Disorders ....... 28

3

29. Fiscal Year (FY) 2019 Integrated Behavioral Health Services (IBHS) ..................................................................... 29

30. Opioid Workforce Expansion Program (OWEP) Paraprofessionals ...................................................................... 29

31. Opioid Workforce Expansion Program (OWEP) Professionals .............................................................................. 30

32. Graduate Psychology Education (GPE) Program ................................................................................................... 31

33. Rural Communities Opioid Response Program-Implementation ......................................................................... 31

34. Rural Communities Opioid Response Program-Evaluation .................................................................................. 33

35. Small Health Care Provider Quality Improvement Program ................................................................................. 33

36. Strengthening Systems of Care for People Living with HIV and Opioid Use Disorder .......................................... 34

37. Rural Residency Planning and Development Program ......................................................................................... 35

38. Rural Health Innovation and Transformation Technical Assistance ..................................................................... 35

39. U3D Maternal and Child Health Measurement Research Network (MRN) .......................................................... 36

40. Small Rural Hospital Improvement Program ........................................................................................................ 37

41. Rural Health Network Development Planning Program ....................................................................................... 37

42. Rural Communities Opioid Response Program – Technical Assistance ................................................................ 38

43. Rural Communities Opioid Response Program - Planning .................................................................................... 39

CURRENT FUNDING PROGRAMS THROUGH NATIONAL INSTITUTE OF HEALTH: .......................................................... 39

44. NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional) ............................................... 39

45. Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention ... 40

46. Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional) ............................................. 41

47. HEAL Initiative: America’s Startups and Small Businesses Build Technologies to Stop the Opioid Crisis (R43/R44

- Clinical Trial Optional) ..................................................................................................................................................... 42

48. HEAL Initiative: America’s Startups and Small Businesses Build Technologies to Stop the Opioid Crisis (R41/R42


49. Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R01


50. Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R21


51. NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed) ...... 45

52. Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders

(R34 Clinical Trial Optional) ............................................................................................................................................... 46

53. Pilot and Feasibility Studies in Preparation for Drug and Alcohol Abuse Prevention Trials (R34 Clinical Trial

Optional) ........................................................................................................................................................................... 47

54. Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01

Clinical Trial Optional) ....................................................................................................................................................... 48

55. Multi-Site Pilot & Feasibility Studies for System-Level Implementation of Substance Use Prevention and

Treatment Services (R34 Clinical Trial Optional) .............................................................................................................. 49

56. Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the

U.S. (R21 Clinical Trial Optional) ....................................................................................................................................... 50

4

57. Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the

U.S. (R01 Clinical Trial Optional) ....................................................................................................................................... 51

PAST FUNDING PROGRAMS THROUGH NATIONAL INSTITUTE OF HEALTH: ................................................................. 52

58. HEAL Initiative: Antenatal Opioid Exposure Longitudinal Study Consortium (PL1 Clinical Trial Not Allowed)..... 52

59. HEAL Initiative: Integrated Approach to Pain and Opioid Use in Hemodialysis Patients: The Hemodialysis Opioid

Prescription Effort (HOPE) Consortium - Clinical Centers (U01 Clinical Trial Required) ................................................... 53

60. HEAL Initiative: Biofabricated 3D Tissue Models of Nociception, Opioid Use Disorder and Overdose for Drug

Screening (UH2/UH3 Clinical Trial Not Allowed) .............................................................................................................. 54

61. HEAL Initiative: Tissue Chips to Model Nociception, Addiction, and Overdose (UG3/UH3 Clinical Trial Not

Allowed) ............................................................................................................................................................................ 55

[email protected] ..................................................................................................................................................... 56

62. HEAL Initiative: Justice Community Opioid Innovation Network (JCOIN) Clinical Research Centers (UG1 Clinical

Trial Optional) ................................................................................................................................................................... 56

63. HEAL Initiative: Justice Community Opioid Innovation Network Coordination and Translation Center .............. 57

CURRENT FUNDING PROGRAMS THROUGH DOJ’S OFFICE OF JUSTICE PROGRAMS (OJP): ........................................... 58

64. Justice and Mental Health Collaboration Program FY 2019 Competitive Grant Announcement (BJA) ............... 58

PAST FUNDING PROGRAMS THROUGH OJP:.............................................................................................................. 59

66. Improving Reentry for Adults with Co-occurring Substance Abuse and Mental Illness (BJA) .............................. 59

67. Second Chance Act Comprehensive Community-based Adult Reentry Program (BJA) ........................................ 60

68. Improving Justice and Mental Health Collaboration: Training and Technical Assistance to Grantees and the

Field (BJA) .......................................................................................................................................................................... 61

69. Comprehensive Opioid Abuse Site-based Program (BJA) ..................................................................................... 62

70. Juvenile Drug Treatment Court Program (OJJDP) ................................................................................................. 63

71. Family Drug Court Program (OJJDP) ..................................................................................................................... 64

72. Office Anti-Heroin Task Force (AHTF) Program Application Guide (COPS) ........................................................... 65

73. Tribal Justice CTAS Training and Technical Assistance Solicitation (BJA).............................................................. 66

74. Opioid Affected Youth Initiative (OJJDP) .............................................................................................................. 66

75. Drug Court Training and Technical Assistance Program (OJJDP) .......................................................................... 67

76. Research and Evaluation on Drugs and Crime (NIJ) .............................................................................................. 68

77. Residential Substance Abuse Treatment (RSAT) for State Prisoners Program ..................................................... 69

78. Mentoring Opportunities for Youth Initiative: Category 1-5: (OJJDP) .................................................................. 69

79. Innovative Prosecution Solutions for Combating Violent Crime (BJA) ................................................................. 71

80. Adult Drug Court Discretionary Grant Program (BJA) ........................................................................................... 72

81. Adult Drug Court and Veterans Treatment Court Planning, Training, Technical Assistance and Resource Center

Initiative (BJA) ................................................................................................................................................................... 73

82. U.S. Department of Justice Coordinated Tribal Assistance Solicitation ................................................................ 73

5

Overview of Resources to Help Ohio Communities Combat the Opioid Epidemic

The Comprehensive Addiction and Recovery Act:

On July 22, 2016, President Obama signed into law Senator Portman’s Comprehensive Addiction and Recovery Act

(CARA), which fundamentally transforms the way the federal government treats addiction. CARA was funded at $267

million for Fiscal Year 2017. The Trump Administration’s FY 2019 budget includes $17 billion in resources to combat

the opioid epidemic. In addition, the bipartisan congressional budget deal includes $6 billion in additional resources for

FYs 2018-2019.

CARA Policy Reforms Implemented by Federal Agencies:

• Nurse practitioners and physicians assistants are now able to provide life-saving medication-assisted treatment.

• States, hospitals and social services will now report, track and assist drug dependent newborns and their families.

• The Department of Veterans Affairs (VA) will follow opioid prescribing guidelines and put in place stronger

oversight and accountability for the quality of care that they are providing our veterans. The VA will increase

coordination and communication throughout the VA with medical facilities, providers, patients and their families

and will hold the VA system accountable for appropriate care and quality standards. The VA will strengthen patient

advocacy programs, expands access to integrative health and wellness, and enhance VA hiring practices to help

prevent bad doctors from treating veterans.

Sample of CARA Grant Awards:

• $400,000 to establish or enhance local drug courts.

• $150,000 to expand addiction recovery support services.

• $300,000 for drug overdose outreach projects to fund new approaches to connect an overdose survivor to treatment

services.

• $750,000 to pilot programs that use technology to expand treatment and recovery support services for individuals in

rural areas.

• $400,000 for diversion and alternative to incarceration projects in the criminal justice system.

• $100,000 to fund statewide planning, coordination, and implementation projects between the criminal justice system

and addiction and mental health services.

• $400,000 to enhance prescription drug monitoring programs.

• More grant options included in this document.

Outstanding Actions to Fully Implement CARA:

• Inter-Agency Task Force on Best Practices for Prescribers of Pain Medication - Report on pain management

research and opioid prescribing and develop a strategy for disseminating information about best practices for pain

management, opioid prescribing, and alternatives to opioids.

• National Public Awareness Campaign - National education and awareness campaign to address the dangers of

opioid abuse and the association between prescription opioid abuse and heroin use and the dangerous effects of

fentanyl.

• Expand Prescription Drug Take Back Programs - Coordinate with law enforcement, hospitals, and pharmacies to

expand or make available disposal sites for unwanted prescription medications.

• Information Materials and Resources to Prevent Addiction Related to Youth Sports Injuries - Information focused

on youth sports injuries and the risks associated with opioid use and misuse, treatment options for such injuries that

do not involve the use of opioids, and how parents and youth can seek treatment for addiction.

• FDA Action Plan on Approving New Opioids - FDA must seek recommendations from an advisory committee prior

to approving any new opioid and must specifically label any drug that is an opioid intended for use in pediatric

populations. FDA must develop and dispense guidance on educating prescribers on opioid abuse and the use of

abuse deterrent opioids.

• Opioid Research by the National Institute of Health - Intensify and coordinate clinical research with respect to

understanding pain, developing alternative therapies for chronic pain, and developing alternatives to opioids for

effective pain treatments.

6

The 21st Century Cures Act:

On December 13, 2016, President Obama signed legislation to provide $1 billion to combat the opioid crisis. Ohio

received $26 million in Fiscal Year 2017 to help address the opioid crisis by increasing access to treatment, reducing

unmet treatment needs, and reducing opioid-related overdose deaths. Cures Act Funding Opportunities can be found at

this link on the Ohio Department of Mental Health and Addiction Services’ website:

http://mha.ohio.gov/Default.aspx?tabid=889.

Grants through OhioMHAS of FY19:

Emergency Department CURES Grant RFA (July 12): OMHAS seeks to fund case management positions in up four

additional hospital emergency department settings to coordinate clinical care for persons with substance use disorders

including opioid use disorders (SUD/OUD).

Request for Proposals (RFP) Behavioral Health and Juvenile Justice (June 10): OMHAS seeks to build upon the

earlier generations of the mental health service activities for juvenile justice-involved youth and supports a solid

foundation of community collaboration. Improvements may include prevention, early identification, evidence based/

informed practices and treatment models; and, sharing resources and developing partnerships between communities’

caregivers and service systems, and their counterparts at the state level.

RFI Understanding the Status of Kindergarten-12 Grade Prevention Education in Ohio (June 5): OHMAS seeks to

understand the status of kindergarten through grade 12 prevention education across the state. Its findings will be used to

inform future state-level investments and opportunities aimed at helping communities build and leverage partnerships to

deploy prevention education practices.

SOR Provide or Expand Peer Supports Initiative for Persons in Recovery from OUD (May 10): OMHAS seeks to

increase the availability of peer supports for persons in recovery from OUD and their families, including persons on all

forms of medication assisted treatment for OUD.

SOR MOMS Trainer Grant RFA (April 26): OMHAS seeks to award funding to one entity to provide training on the

Maternal Opiate Medical Supports model of care for pregnant women with opioid use disorder.

MOMS Implementation Site Grant (April 26): OMHAS seeks to award funding to support maternal care homes that

provide timely access to appropriate addiction and mental health services during pregnancy that extends postpartum,

including intensive home-based or residential treatment.

SOR Housing for Persons in Recovery from OUD Initiative (April 12): OMHAS seeks to increase the availability of

housing for persons in recovery from OUD and their families, including recovery housing that accepts all forms of

medication assisted treatment for OUD. Applications will be accepted from any ADAMHS county board.

Youth Resiliency Program (February 28): OMHAS seeks to award funding to support youth resiliency programming

for at-risk youth. Under this program, organizations may apply for one-time, stop-gap funding to help develop and/or

build capacity for services and programming designed to ensure that at-risk youth enjoy healthy development, succeed in

school, and grow up to be productive, adult citizens.

RFA SOR GPRA (February 22): OMHAS seeks to partner with a college or university to manage the required

Government Performance and Results Act (GPRA) survey data collection and reporting for the Ohio SOR project. The

selected applicant will provide training and support to the SOR providers collecting required Government Performance

and Results Act (GPRA) data, monitor data collected for data integrity, and regularly report to OMHAS relating to the

data collection process.

SOR Medical School Curriculum Program (February 22): OMHAS seeks to award funding to develop and implement

a common curriculum across all Ohio Medical schools to train 11,000 graduate medical students per year on pain

management and opioid use disorder treatment.

http://mha.ohio.gov/Default.aspx?tabid=889

7

SOR Quality Housing Criteria (January 26): OMHAS is offering one statewide grant to a Housing Advocacy

Organization to assist with administrative duties related to the Quality Housing Criteria.

SOR Local Projects Funding (January 25): OMHAS seeks to partner with local ADAMHS boards to implement

treatment and recovery programs that expand access to medication assisted treatment (MAT).

Ohio Institutional Expert MAT WAIVER Trainer Live and In-person Training (December 28, 2018): OMHAS

seeks to partner with ten (10) hospitals with active and accredited residency programs across Ohio to provide DEA DATA

2000 Waiver trainings for resident physicians and physicians in Ohio.

SOR Distribution of Drug Destruction Bags (December 14, 2018): OMHAS seeks to award funding to one entity to

purchase and distribute drug destruction bags to community networks such as senior centers, schools, police and fire

departments, and hospitals.

Opioid Sequential Intercept Mapping (SIM) Action Plan (December 3, 2018): OMHAS will provide funding to

support up to three county ADAMHS Boards that have participated in an Opioid Sequential Intercept Mapping (SIM)

Workshop offered by Northeast Ohio Medical University (NEOMED). As part of the SIM workshop, participants are

tasked with developing an action plan which identifies top priority areas to help improve system and service level

responses for criminal justice involved individuals with an opioid use disorder (OUD).

SOR Ohio SBIRT Trainer (November 30, 2018): OMHAS seeks to expand Screening, Brief Intervention and Referral

to Treatment (SBIRT) training by partnering with three non-profit, accredited, universities or colleges to provide SBIRT

training for healthcare organizations within their awarded catchment area. SBIRT is an evidence based practice used to

identify, reduce, and prevent opioid use disorder.

Guidelines for MAT Transition of Care (November 23, 2018): OMHAS seeks to award funding to one entity to

develop inpatient medical setting guidelines for providing services and transitioning care of patients with opioid use

disorders (OUD) and/or other substance use disorders (SUD).

Ohio Institutional Expert MAT Trainer Grant (October 26, 2018): OMHAS seeks to partner with ten hospitals with

active and accredited residency programs across Ohio to provide DEA DATA 2000 Waiver trainings for resident

physicians and physicians in Ohio. The awardee will have two of their waivered physicians engage with Providers

Clinical Support System (PCSS) to complete PCSS requirements to become a Course Instructor for MAT Waiver

Training. The hospital will then sponsor two (2) MAT Waiver Trainings at their facility for physicians and resident

physicians both at their hospital and/or from other areas in the grant year.

MOMS Trainer Grant (August 27, 2018): OMHAS seeks to award funding to one entity to provide training on the

Maternal Opiate Medical Supports model of care for pregnant women with opioid use disorder.

Senator Portman’s Grant Coordinator: Avery Pierson

[email protected] or [email protected]

614.469.6774

Fiscal Year 2019 Grant Announcements and Awards:

https://www.samhsa.gov/grants/grant-announcements-2019

Developing a Competitive SAMHSA Grant Application:

https://www.samhsa.gov/sites/default/files/sites/default/grant_application_manual_508_compliance.pdf

SAMHSA Applicant Webinar for FY 2018:

https://www.youtube.com/watch?v=BFluJUvrM-g&feature=youtu.be

https://www.samhsa.gov/grants/grant-announcements-2019

https://www.samhsa.gov/sites/default/files/sites/default/grant_application_manual_508_compliance.pdf

https://www.youtube.com/watch?v=BFluJUvrM-g&feature=youtu.be

8

Listing of Grant Drug-Treatment Related Postings through the U.S. Department of Health & Human Services Substance

Abuse and Mental Health Services Administration

CURRENT FUNDING PROGRAMS THROUGH SAMHSA:

1. Mental and Substance Use Disorders Prevalence Study

https://www.samhsa.gov/grants/grant-announcements/fg-19-003

FOA Number: FG-19-003 Application Due Date: Friday, August 16, 2019

Description: The purpose of this grant program is to ensure that gaps in surveillance of individuals with serious mental

illness are addressed through a pilot program which assists in estimating the actual number of individuals living with

mental and substance use disorders, including those of the greatest severity.

Eligibility:

Domestic public and private non-profit entities.

Anticipated Total Available Funding: $30 million Anticipated Number of Awards: One

Length of Project: 3 years

Cost Sharing/Match Required?: No

Proposed budgets cannot exceed $30,000,000 in total costs (direct and indirect) in any year of the proposed project.

Annual continuation awards will depend on the availability of funds, grantee progress in meeting project goals and

objectives, timely submission of required data and reports, and compliance with all terms and conditions of award.

Contact Information:

Program Issues

Beverly Vayhinger - Office of Financial Resources

(240) 276-0564

[email protected]

Grants Management and Budget Issues

Eileen Bermudez - Office of Financial Resources, Division of Grants Management

(240) 276-1412

[email protected]

2. Mental and Substance Use Disorder Practitioner Data https://www.samhsa.gov/grants/grant-announcements/fg-19-002

FOA Number: FG-19-002 Application Due Date: Monday, August 12, 2019

Description: The purpose of this program is to provide comprehensive data and analysis on individuals who comprise the

prevention and treatment fields to address mental and substance use disorders. The goal of the program is to provide valid

data on the existing practitioners and usable information to SAMHSA on which to make policy and planning decisions.

Eligibility:

Public or private non-profit domestic entities

Anticipated Total Available Funding: $1 million Anticipated Number of Awards: One


mailto:[email protected]



9

Anticipated Award Amount: $1 million Length of Project: 3 years


Proposed budgets cannot exceed $1,000,000 in total costs (direct and indirect) in any year of the proposed project. Annual

continuation awards will depend on the availability of funds, grantee progress in meeting project goals and objectives,

timely submission of required data and reports, and compliance with all terms and conditions of award.


Program Issues


(240) 276-1412

[email protected]



(240) 276-1412

[email protected]

3. Tribal Opioid Response Grants https://www.samhsa.gov/grants/grant-announcements/ti-19-012

FOA Number: TI-19-012 Application Due Date: Tuesday, August 6, 2019

Description: The purpose of this program is to address the opioid crisis in tribal communities by increasing access to

culturally appropriate and evidence-based treatment, including medication-assisted treatment (MAT) using one of the

three FDA-approved medications for the treatment of opioid use disorder (OUD). The intent is to reduce unmet treatment

need and opioid overdose-related deaths through the provision of prevention, treatment and/or recovery activities for

OUD.

Eligibility:

Federally recognized tribes and tribal organizations. Tribes and tribal organizations may elect to apply as part of a

consortia or in partnership with urban Indian organizations. Tribes and tribal organizations may only be included

in one grant application.

Anticipated Total Available Funding: $35,985,372 Anticipated Number of Awards: 163

Anticipated Award Amount: See Appendix K of FOA (varies by tribe) Length of Project: 2 years


Annual continuation awards will depend on the availability of funds, grantee progress in meeting project goals and



Program Issues

[email protected]


[email protected]



https://www.samhsa.gov/grants/grant-announcements/ti-19-012



10

4. Expansion of Practitioner Education https://www.samhsa.gov/grants/grant-announcements/fg-19-001

FOA Number: FG-19-001 Application Due Date: Friday, August 2, 2019

Description: The purpose of this program is to expand the integration of substance use disorder (SUD) education into the

standard curriculum of relevant healthcare and health services education programs. Through the mainstreaming of this

education, the ultimate goal is to expand the number of practitioners to deliver high-quality, evidence-based SUD

treatment.

Eligibility:

Public or private non-profit professional organizations representing healthcare professionals in the fields of

medicine, physician assistants, nursing, social work, psychology, marriage and family therapy, health services

administration.

Anticipated Total Available Funding: $2.5 million Anticipated Number of Awards: 10

Anticipated Award Amount: $250,000 Length of Project: 2 years


Proposed budgets cannot exceed $250,000 in total costs (direct and indirect) in any year of the proposed project. Annual


timely submission of required data and reports, and compliance with all terms and conditions of award.)


Program Issues


(240) 276-1412

[email protected]



(240) 276-1412

[email protected]

5. Drug-Free Communities (DFC) Support Program - New https://www.samhsa.gov/grants/grant-announcements/sp-19-005

FOA Number: SP-19-005 Application Due Date: Monday, July 8, 2019

Description: The purpose of this program is to establish and strengthen collaboration among communities, public and

private non-profit agencies, as well as federal, state, local, and tribal governments to support the efforts of community

coalitions working to prevent and reduce substance abuse among youth. In addition to this, another purpose is to reduce

substance abuse among youth and, over time, reduce substance abuse among adults by addressing the factors in a

community that increase the risk of substance abuse and promoting the factors that minimize the risk of substance abuse.

Eligibility:

Community-based coalitions addressing youth substance use that have never received a DFC grant.

Must meet all statutory eligibility requirements which are summarized in Table 1 in the DFC Act.




https://www.samhsa.gov/grants/grant-announcements/sp-19-005

11


Anticipated Award Amount: Up to $125,000 per year Length of Project: Up to 5 years

Cost Sharing/Match Required?: Yes





Program Issues

DFC FOA Helpline Team

Office of Drug-Free Communities

[email protected]


Odessa Crocker - Office of Financial Resources Division of Grants Management

5600 Fishers Lane

Rockville, Maryland 20857

[email protected]

6. Drug-Free Communities (DFC) Support Program – Competing Continuation https://www.samhsa.gov/grants/grant-announcements/sp-19-006

FOA Number: SP-19-006 Application Due Date: Monday, July 8, 2019

Description: The purpose of this program is to establish and strengthen collaboration among communities, public and

private non-profit agencies, as well as federal, state, local, and tribal governments to support the efforts of community

coalitions working to prevent and reduce substance abuse among youth. In addition to this, another purpose is to reduce

substance abuse among youth and, over time, reduce substance abuse among adults by addressing the factors in a

community that increase the risk of substance abuse and promoting the factors that minimize the risk of substance abuse.

Eligibility:

Community-based coalitions addressing youth substance use that have previously received a DFC grant but

experienced a lapse in funding or have concluded the first five-year funding cycle and are applying for a second

five-year funding cycle.

Must meet all statutory eligibility requirements which are summarized in Table 1 in the DFC Act.








Program Issues

DFC FOA Helpline Team

Office of Drug-Free Communities

[email protected]





12


Odessa Crocker - Office of Financial Resources Division of Grants Management

5600 Fishers Lane

Rockville, Maryland 20857

[email protected]

PAST FUNDING PROGRAMS THROUGH SAMHSA:

7. Rural Opioid Technical Assistance Grants https://www.samhsa.gov/grants/grant-announcements/ti-19-010

FOA Number: TI-19-010 Application Due Date: Friday, June 7, 2019

Description: The purpose of this program is to develop and disseminate training and technical assistance for rural

communities on addressing opioid issues affecting these communities. It is expected that grantees will facilitate the

identification of model programs, develop and update materials related to the prevention, treatment and recovery activities

for opioid use disorder (OUD), and ensure that high-quality training is provided.

Eligibility:

Existing USDA Cooperative Extensions grantees

ROTA grantees that received an award in FY 2018 under announcement TI-18-022 are not eligible to apply








Program Issues

Humberto Carvalho - Center for Substance Abuse Treatment, Division of Service Improvement

(240) 276-2974

[email protected]



(240) 276-1412

[email protected]

8. Provider’s Clinical Support System – Universities Grants https://www.samhsa.gov/grants/grant-announcements/ti-19-011

FOA Number: TI-19-011 Application Due Date: Friday, June 7, 2019






13

Description: The purpose of this program is to expand/enhance access to medication-assisted treatment (MAT) services

for persons with an opioid use disorder (OUD) seeking or receiving MAT through ensuring the education and training of

students in the medical, physician assistant and nurse practitioner fields. This program’s focus is to ensure students fulfill

the training requirements needed to obtain a DATA waiver to prescribe MAT in office-based settings. The desired

outcomes include: 1) an increase in the number of individuals completing the training requirements for the DATA waiver,

2) an increase the number of individuals with a DATA waiver, and 3) an ultimate increase in those prescribing.

Eligibility:

Eligible applicants are medical schools, physician assistant schools, and schools of nursing

PCSS-Universities grantees that received an award in FY 2018 under announcement TI-18-014 are not eligible to

apply for this program.

Anticipated Total Available Funding: $3 million Anticipated Number of Awards: 20







Program Issues

Anthony Campbell RPH, D.O. - Division of Pharmacologic Therapy, Center for Substance Abuse Treatment

(240) 276-2702

[email protected]



(240) 276-1412

[email protected]

9. National Evaluation of the Technology Transfer Center Program https://www.samhsa.gov/grants/grant-announcements/ti-19-009

FOA Number: TI-19-009 Application Due Date: Friday, May 17, 2019

Description: In FY 2018, SAMHSA reconfigured its approach to training and technical assistance by establishing a

national network of regional technology transfer centers for substance abuse prevention and mental health services in

addition to the existing centers for addiction technology transfer. The fundamental premise of this new approach was the

broad dissemination of evidence-based practices to best equip the healthcare workforce with the skills needed to address

substance abuse prevention and the treatment of mental and substance use disorders whether or not this workforce was a

beneficiary of SAMHSA grant funding. The purpose of the National Evaluation is to gauge the extent to which this effort

has been effective.

Eligibility:

Domestic public and private nonprofit entities

Anticipated Total Available Funding: $750,000 Anticipated Number of Awards: One





14






Program Issues

Humberto Carvalho – Office of Financial Resources

(240) 276-2974

[email protected]



(240) 276-1412

[email protected]

10. Transforming Lives Through Supported Employment https://www.samhsa.gov/grants/grant-announcements/sm-19-011

FOA Number: SM-19-011 Application Due Date: Friday, May 17, 2019

Description: The purpose of the program is to support state and community efforts to refine, implement, and sustain

evidence-based supported employment programs and mutually compatible and supportive evidence-based practices (e.g.,

supported education) for transition-aged youth/young adults (ages 16-25) with serious emotional disturbance (SED), and

adults with serious mental illness (SMI) or co-occurring mental and substance use disorders (COD).

Eligibility:

Domestic public and private nonprofit entities

Anticipated Total Available Funding: $5,792,761 Anticipated Number of Awards: Seven







Program Issues

Mary Blake - Community Support Programs Branch

Division of Services and Systems Improvement - Center for Mental Health Services

(240) 276-0625

[email protected]

Rachel Steidl - Community Support Programs Branch

Division of Services and Systems Improvement - Center for Mental Health Services

(240) 276-0625

[email protected]





https://www.samhsa.gov/grants/grant-announcements/sm-19-011



15

(240) 276-1412

[email protected]

11. First Responders-Comprehensive Addiction and Recovery Act https://www.samhsa.gov/grants/grant-announcements/ti-19-004

FOA Number: TI-19-004 Application Due Date: Monday, May 6, 2019

Description: The purpose of this program is to allow first responders and members of other key community sectors to

administer a drug or device approved or cleared under the Federal Food, Drug, and Cosmetic Act for emergency treatment

of known or suspected opioid overdose. Recipients will train and provide resources to first responders and members of

other key community sectors at the state, tribal, and local governmental levels on carrying and administering a drug or

device approved or cleared under the Federal Food, Drug, and Cosmetic Act for emergency treatment of known or

suspected opioid overdose. Recipients will also establish processes, protocols, mechanisms for referral to appropriate

treatment and recovery communities, and safety around fentanyl, carfentanil, and other dangerous licit and illicit drugs.

For the purposes of this funding opportunity announcement (FOA), first responders include firefighters, law enforcement

officers, paramedics, emergency medical technicians, or other legally organized and recognized volunteer organizations

that respond to adverse opioid related incidents.

Eligibility:

State governments;

Federally recognized American Indian/Alaska Native (AI/AN) tribes, tribal organizations, Urban Indian

Organizations, and consortia of tribes or tribal organizations; and

Local governmental entities including, but not limited to, municipal corporations, counties, cities, boroughs,

incorporated towns, and townships.

Anticipated Total Available Funding: $16.5 million Anticipated Number of Awards: Up to 45

Anticipated Award Amount: $250,000 to $800,000 per year Length of Project: Up to 4 years


Proposed budgets cannot exceed $250,000 - $800,000 in total costs (direct and indirect) in any year of the proposed

project. Annual continuation awards will depend on the availability of funds, grantee progress in meeting project goals

and objectives, timely submission of required data and reports, and compliance with all terms and conditions of award.)


Program Issues

Judith Ellis - SAMHSA/CSAP

(240) 276-2567

[email protected]



(240) 276-1412

[email protected]

12. Minority Aids Initiative: Substance Use Disorder Treatment for Racial/Ethnic

Minority Populations at High Risk for HIV/AIDS https://www.samhsa.gov/grants/grant-announcements/ti-19-008






16

FOA Number: TI-19-008 Application Due Date: Monday, April 22, 2019

Description: The purpose of this program is to increase engagement in care for racial and ethnic minority individuals

with substance use disorders (SUD) and/or co-occurring substance use and mental disorders (COD) who are at risk for

HIV or are HIV positive that receive HIV services/treatment.

Eligibility:

Domestic public and private nonprofit entities.

Grantees that received awards under TI-17-011 in FY 2017 and FY 2018 are not eligible to apply.

Anticipated Total Available Funding: $12 million Anticipated Number of Awards: 24

Anticipated Award Amount: $500,000 per year Length of Project: Up to 5 years






Program Issues Kirk James, M.D. - Center for Substance Abuse Treatment, Division of Services Improvement

(240) 276-1617

[email protected]

Grants Management and Budget Issues Eileen Bermudez - Office of Financial Resources, Division of Grants Management

(240) 276-1412

[email protected]

13. Building Communities of Recovery


FOA Number: TI-19-003 Application Due Date: April 2, 2019

Description: The purpose of this program is to mobilize resources within and outside of the recovery community to

increase the prevalence and quality of long-term recovery support from substance abuse and addiction. These grants are

intended to support the development, enhancement, expansion, and delivery of recovery support services (RSS) as well as

promotion of and education about recovery. Programs will be principally governed by people in recovery from substance

abuse and addiction who reflect the community served.

Grantees may use funds to: 1) build connections between recovery networks, between RCOs, and with other RSS; 2)

reduce the stigma associated with drug/alcohol addiction; and 3) conduct public education and outreach on issues relating

to drug/alcohol addiction and recovery.

Eligibility:

RCOs that are domestic private nonprofit entities in states, territories, or tribes.

Anticipated Total Available Funding: $521,000 Anticipated Number of Awards: 3

Anticipated Award Amount: $200,000 Length of Project: Up to 3 years




17






Program Issues

Robert W. Day, MPH, MA - Center for Substance Abuse Treatment, Division of Services Improvement

(240) 276-2569

[email protected]



(240) 276-1412

[email protected]

14. National Center of Excellence for Integrated Health Solutions https://www.samhsa.gov/grants/grant-announcements/sm-19-012

FOA Number: SM-19-012 Application Due Date: March 29, 2019

Description: The purpose of this program is to advance the implementation of high quality, evidence-based treatment for

individuals with co-occurring physical and mental health conditions, including substance use disorders. Data demonstrate

that individuals with mental health conditions are far more likely to also experience physical health conditions. The co-

occurrence of these conditions necessitates the delivery of holistic, integrated care. The goal of this grant is to ensure that

these services are provided in the most effective manner possible.

Eligibility:


Anticipated Total Available Funding: $2,000,000 Anticipated Number of Awards: One

Anticipated Award Amount: Up to $2,000,000 per year Length of Project: Up to 5 years


Proposed budgets cannot exceed $2,000,000 in total costs (direct and indirect) in any year of the proposed project. Annual




Program Issues

Tenly Biggs - Center for Mental Health Services

(240) 276-2411

[email protected]



(240) 276-1412

[email protected]






18

15. Strategic Prevention Framework – Partnerships for Success


FOA Number: SP-19-004 Application Due Date: March 29, 2019

Description: The purpose of this grant program is to prevent the onset and reduce the progression of substance abuse and

its related problems while strengthening prevention capacity and infrastructure at the community level. The program is

intended to address one of the nation’s top substance abuse prevention priorities - underage drinking among persons aged

9 to 20. At their discretion, recipients may also use grant funds to target up to two additional, data-driven substance abuse

prevention priorities, such as the use of marijuana, cocaine, opioids, or methamphetamine, etc. by individuals ages 9 and

above.

Eligibility:

Local-level domestic public and private nonprofit entities.

Grant recipients who have received funding under SP-16-003 and SP-18-008 are not eligible to apply for funding

under this FOA.

States are not eligible to apply.

Anticipated Total Available Funding: Approximately $38,000,000 Anticipated Number of Awards: 127




continuation awards will depend on the availability of funds, recipient progress in meeting project goals and objectives,



Program Issues

Tonia F. Gray, MPH

Division of State Programs

Center for Substance Abuse Prevention

(240) 276-2492

[email protected]

Kameisha Bennett

Division of State Programs

Center for Substance Abuse Prevention

(240) 276-2586

[email protected]



(240) 276-1412

[email protected]

16. Targeted Capacity Expansion: Special Projects


FOA Number: TI-19-007 Application Due Date: March 25, 2019

Description: The purpose of this program is to develop and implement targeted strategies for substance use disorder

treatment provision to address a specific population or area of focus identified by the community. The purpose of the TCE

program is to address an unmet need or underserved population; this program aims to enable a community to identify the






19

specific need or population it wishes to address through the provision of evidence-based substance use disorder treatment

and/or recovery support services.

Eligibility:


Anticipated Total Available Funding: Approximately $8.3 million Anticipated Number of Awards: 22







Program Issues

[email protected]



(240) 276-1412

[email protected]

17. Provider’s Clinical Support System – Medication Assisted Treatment Grant


FOA Number: TI-19-005 Application Due Date: February 26, 2019

Description: The purpose of this program is to expand the number of Drug Addiction Treatment Act (DATA) 2000

waived providers, increase understanding of the importance of medication-assisted treatment and ultimately increase

access to MAT through expanded prescribing of FDA-approved medications for the treatment of opioid use disorders.

Although the current initiative has provided multiple trainings and mentoring support, there still remains a significant

need to increase the number of healthcare providers to address the nation’s lack of adequate access to care and treatment

for opioid and other substance use disorders. The PCSS-MAT program will continue to provide up-to-date and evidence-

based information to support the training of health professionals and to address the complex issues of addiction.

Eligibility:

Limited to the national professional medical organizations authorized to carry out the training of providers

desiring to prescribe and/or dispense FDA-approved schedule III medications for addictive disorders. These

organizations are the American Society of Addiction Medicine (ASAM), the American Academy of Addiction

Psychiatry (AAAP), the American Medical Association (AMA), the American Osteopathic Academy of

Addiction Medicine (AOAAM), and the American Psychiatric Association (APA). Any of these entities may

apply individually; they may also apply as a consortium comprised of all or several of the eligible organizations.

If a consortium is formed for this purpose, a single organization in the consortium must be the legal applicant, the

recipient of the award, and the entity legally responsible for satisfying the grant requirements. If a consortium

submits an application, a written agreement must be included outlining the roles and responsibilities of each

participating national professional medical organization.

Anticipated Total Available Funding: $2,000,000 Anticipated Number of Awards: one





20


Proposed budgets cannot exceed $2 million in total costs (direct and indirect) in any year of the proposed project. Annual




Program Issues

Anthony Campbell RPH, D.O. - Division of Pharmacologic Therapy, Center for Substance Abuse Treatment

(240) 276-2702

[email protected]



(240) 276-1412

[email protected]

18. Grants to Expand Substance Abuse Treatment Capacity in Family Drug Courts


FOA Number: TI-19-001 Application Due Date: January 4, 2019

Description: The purpose of this program is to expand substance use disorder (SUD) treatment services in existing family

treatment drug courts, which use the family treatment drug court model in order to provide alcohol and drug treatment

(including recovery support services, screening, assessment, case management, and program coordination) to parents with

a SUD and/or co-occurring SUD and mental disorders who have had a dependency petition filed against them or are at

risk of such filing. Services must address the needs of the family as a whole and include direct service provision to

children (18 and under) of individuals served by this project.

Recipients will be expected to provide a coordinated, multi-system approach designed to combine the sanctioning power

of treatment drug courts with effective treatment services promoting successful family preservation and reunification.

Priority funding should address gaps in the treatment continuum for court involved individuals who need treatment for a

SUD and/or co-occurring SUD and mental disorders while simultaneously addressing the needs of their children.

The expectations of the grant are to provide funding for FTDCs to assist participants in reducing the rates of substance

misuse, the severity of SUDs and co-occurring disorders, and decreasing out of home placements for children through

family reunification and preservation. This, in turn, should also decrease the number of parents or guardians whose

parental rights have been or will be terminated.

Eligibility:

State governments; the District of Columbia, Guam, the Commonwealth of Puerto Rico, the Northern Mariana

Islands, the Virgin Islands, American Samoa, the Federated States of Micronesia, the Republic of the Marshall

Islands, and the Republic of Palau are also eligible to apply.

Governmental units within political subdivisions of a state, such as a county, city or town.

Federally recognized American Indian/Alaska Native (AI/AN) tribes, tribal organizations, Urban Indian

Organizations, and consortia of tribes or tribal organizations.

Family treatment drug courts that received an award under TI-17-004 and TI-18-002 are not eligible to apply for

this funding opportunity.

Anticipated Total Available Funding: Up to $10,625,000 Anticipated Number of Awards: 25





21






Program Issues

Jon D. Berg - Center for Substance Abuse Treatment, Division of Service Improvement

(240) 276-1609

[email protected]



(240) 276-1412

[email protected]

19. Grants to Expand Substance Abuse Treatment Capacity in Adult Treatment

Drug Courts and Adult Tribal Healing to Wellness Courts


FOA Number: TI-19-002 Application Due Date: January 4, 2019

Description: The purpose of this program is to expand substance use disorder (SUD) treatment services in existing adult

problem solving courts, and adult Tribal Healing to Wellness courts, which use the treatment drug court model in order to

provide SUD treatment (including recovery support services, screening, assessment, case management, and program

coordination) to defendants/offenders.

Recipients will be expected to provide a coordinated, multi-system approach designed to combine the sanctioning power

of treatment drug courts with effective SUD treatment services to break the cycle of criminal behavior, alcohol and/or

drug use, and incarceration or other penalties. Applicants should propose to increase access and availability of services to

a larger number of clients increasing the number of individuals served and the gaps in the continuum of treatment for

individuals in these courts who have treatment needs for SUD and/or co-occurring substance use and mental disorders.

Grant funds must be used to serve people diagnosed with a SUD as their primary condition.

Eligibility:

State, local, and tribal governments with direct involvement with the adult treatment drug court/Tribal Healing to

Wellness Court

ATDCs and Adult Tribal Healing to Wellness Courts funded in FY 2017 under announcement TI-17-001 and FY

2018 under announcement TI-18-008 are not eligible to apply for this program.

Anticipated Total Available Funding: Up to $10,000,000 Anticipated Number of Awards: 25







Program Issues



22

Jon D. Berg - Center for Substance Abuse Treatment, Division of Service Improvement

(240) 276-1609

[email protected]



(240) 276-1412

[email protected]

20. Tribal Behavioral Health Grant Program


FOA Number: SM-19-005 Application Due Date: January 4, 2019

Description: The purpose of this program is to prevent and reduce suicidal behavior and substance use, reduce the impact

of trauma, and promote mental health among American Indian/Alaska Native (AI/AN) youth through the age of 24 years.

Native Connections is intended to reduce the impact of mental and substance use disorders, foster culturally responsive

models that reduce and respond to the impact of trauma in AI/AN communities, and allow AI/AN communities to

facilitate collaboration among agencies to support youth as they transition into adulthood.

Eligibility:

American Indian/Alaska Native (AI/AN) tribes, tribal organizations, Urban Indian Organizations, or consortia of

tribes and tribal organizations.

Anticipated Total Available Funding: $12,797,090 Anticipated Number of Awards: Up to 51






Recipient awards will consist of 40 percent CMHS funding (up to $100,000) and 60 percent CSAP funding (up to

$150,000).


Program Issues

Dr. Michelle Carnes - Suicide Prevention Branch,

Division of Prevention, Traumatic Stress, and Special Programs - Center for Mental Health Services

(240) 276-1869

[email protected]


Office of Financial Resources, Division of Grants Management

(240) 276-1408

[email protected]

21. Rural Opioids Technical Assistance Grants






23


FOA Number: TI-18-022 Application Due Date: Thursday, September 20, 2018

Description: The purpose of this program is to develop and disseminate training and technical assistance for rural

communities on addressing opioid issues affecting these communities. It is expected that grantees will facilitate the

identification of model programs, develop and update materials related to the prevention, treatment and recovery activities

for opioid use disorder (OUD), and ensure that high-quality training is provided.

Eligibility:

Existing USDA Cooperative Extensions grantees with a focus on opioids. The list of eligible applicants is in

Appendix L.

Anticipated Total Available Funding: $8,250,000 Anticipated Number of Awards: 15

Anticipated Award Amount: $550,000 per year Length of Project: Up to 2 years

Cost Sharing/Match Required? No





Program Issues: Humberto Carvalho - Center for Substance Abuse Treatment, Division of Service Improvement

(240) 276-2974

[email protected]

Grants Management and Budget Issues:


(240) 276-1412

[email protected]

22. Center of Excellence for Protected Health Information Related to Mental and

Substance Use Disorders


FOA Number: TI-18-021 Application Due Date: Friday, August 17, 2018

Description: The purpose of this program is to establish one National Center of Excellence to develop and disseminate

training, technical assistance, and educational resources for healthcare practitioners, families, individuals, states, and

communities on various privacy laws and regulations as they relate to information about mental and substance use

disorders. These include: the Health Insurance Portability and Accountability Act (HIPAA) and 42 CFR Part 2. The

Center will also address the intersection of these laws and regulations with other privacy laws such as the Family

Education Rights and Privacy Act (FERPA).

Although necessary for the protection of individuals, privacy regulations and laws are often complex and not easily

interpreted. These regulations often create confusion for both practitioners and those seeking/receiving treatment. In many

cases, these regulations are interpreted too stringently such that critical information from families, individuals or other

healthcare practitioners is withheld leading to potential negative consequences. This project aims to address the





24

complexity of these regulations through providing easily understood resources and training materials to simplify the

interpretation and implementation of these regulations.

Eligibility: Eligible applicants are domestic public and private nonprofit entities.

Anticipated Total Available Funding: $1,000,000 Anticipated Number of Awards: one



Proposed budgets cannot exceed $1,000,000 in total costs (direct and indirect) in any year of the proposed

project. Annual continuation awards will depend on the availability of funds, grantee progress in meeting project goals

and objectives, timely submission of required data and reports, and compliance with all terms and conditions of award.


Program Issues: Mitchell Berger

(240) 276-1757

[email protected]

Grants Management and Budget Issues:


(240) 276-1412

[email protected]

23. State Opioid Response Grants


FOA Number: TI-18-015 Application Due Date: Monday, August 13, 2018

Description: The purpose of this program is to address the opioid crisis by increasing access to medication-assisted

treatment using the three FDA-approved medications for the treatment of opioid use disorder, reducing unmet treatment

need, and reducing opioid overdose related deaths through the provision of prevention, treatment and recovery activities

for opioid use disorder (OUD) (including prescription opioids, heroin and illicit fentanyl and fentanyl analogs). These

grants will be awarded to states and territories via formula. The program also includes a 15 percent set-aside for the ten

states with the highest mortality rate related to drug overdose deaths.

The program supplements activities pertaining to opioids currently undertaken by the state agency and will support a

comprehensive response to the opioid epidemic. The results of the assessments will identify gaps and resources from

which to build upon existing substance use prevention and treatment activities as well as community-based recovery

support services. Grantees will be required to describe how they will expand access to treatment and recovery support

services. Grantees will also be required to describe how they will advance substance misuse prevention in coordination

with other federal efforts. Grantees must use funding to supplement and not supplant existing opioid prevention,

treatment, and recovery activities in their state. Grantees are required to describe how they will improve retention in care,

using a chronic care model or other innovative model that has been shown to improve retention in care.

Eligibility:

The Single State Agencies (SSAs) and territories.

Tribes will be eligible to apply for opioid response funding under a separate announcement.

Anticipated Total Available Funding: $930,000,000 (This includes 15% set-aside for the ten states hardest hit by the

crisis).




25

Anticipated Number of Awards: 59

Anticipated Award Amount: See Appendix K for distribution Length of Project: Up to 2 years

Cost Sharing/Match Required? No

State allocations for the Opioid SOR grants are calculated by a formula based on the equal weighting of two elements: the

state’s proportion of people with abuse or dependence on opioids (prescription opioids and/or heroin) who need but do not

receive treatment (NSDUH, 2015-2016) and the state’s proportion of drug poisoning (overdose) deaths (CDC National

Vital Statistics System, 2016). Each State, as well as the District of Columbia, will receive not less than $4,000,000.

Each territory will receive not less than $250,000. See Appendix K for more information. In addition to this base

distribution, $142.5 million in funding is being distributed to the ten states with the highest mortality rates due to drug

poisoning deaths. This set-aside takes into account the state’s ordinal ranking in the top ten; it is not distributed equally

among the ten states.

Annual continuation awards will depend on the availability of funds, recipient progress in meeting project goals and



Program Issues

[email protected]


[email protected]

24. Prevention Technology Transfer Centers Cooperative Agreements


FOA Number: SP-19-001 Application Due Date: Tuesday, July 10, 2018

Description: The purpose of this program is to establish a PTTC Network to provide training and technical assistance

services to the substance abuse prevention field including professionals/pre-professionals, organizations, and others in the

prevention community. The PTTCs will work directly with SAMHSA and across the PTTC Network on activities aimed

at improving implementation and delivery of effective substance abuse prevention interventions. PTTCs will provide

prevention skills trainings and technical assistance services that are: tailored to meet the needs of recipients and the

prevention field; based in prevention science and use evidence-based and promising practices; and leverage the expertise

and resources available through the alliances formed within and across the HHS regions and the PTTC network.

Eligibility:

Domestic public and private not-for-profit entities


Award Amount: From $500,000 to $600,000 per year Length of Project: Up to five years


Proposed budgets cannot exceed the estimated award amounts listed above in total costs (direct and indirect) in any year

of the proposed project. Funding estimates for this announcement are based on the Consolidated Appropriations Act,

2018. Annual continuation awards will depend on the availability of funds, grantee progress in meeting project goals and


• Up to $500,000 per year for the PTTC National Coordinating Center

• Up to $600,000 per year for each of the PTTC Regional Centers




26

• Up to $500,000 per year for the PTTC Tribal Affairs Center

• Up to $500,000 per year for the PTTC Hispanic and Latino Center


Program Issues

Humberto Carvalho - Office of Financial Resources, Office of Management, Analysis, and Coordination

(240) 276-2974

[email protected]



(240) 276-1412

[email protected]

25. Opioid State Targeted Response Technical Assistance


FOA Number: SM-18-019 Application Due Date: Monday, July 9, 2018

Description: The purpose of this program is to increase access to and improve the quality of community behavioral health

services through the expansion of CCBHCs. CCBHCs provide person- and family-centered services and are available in

the 24 states that participated in the FY 2016 Planning Grants for Certified Community Behavioral Health Clinics (SM-

16-001). The CCBHC Expansion grant program must provide access to services for individuals with serious mental illness

(SMI) or substance use disorders (SUD), including opioid disorders; children and adolescents with serious emotional

disturbance (SED); and individuals with co-occurring disorders (COD). The expectation is that this program will improve

the behavioral health of individuals across the nation by providing comprehensive community-based mental and substance

use disorder services; treatment of co-occurring disorders; advance the integration of behavioral health with physical

health care; assimilate and utilize evidence-based practices on a more consistent basis, and promote improved access to

high quality care.

Eligibility:

Certified community behavioral health clinics or community-based behavioral health clinics who may not yet be

certified but meet the certification criteria and can be certified within 4 months of award in the following states:

AK, CA, CO, CT, IA, IL, IN, KY, MA, MD, MI, MN, MO, NC, NJ, NM, NV, NY, OK, OR, PA, RI, TX, and

VA.

Anticipated Total Available Funding: $47,951,359 Anticipated Number of Awards: Up to 25

Anticipated Award Amount: Up to $2,000,000 annually Length of Project: Up to 2 years


Proposed budgets cannot exceed $2,000,000 in total costs (direct and indirect) in any year of the proposed project.

Funding estimates for this announcement are based on the Consolidated Appropriations Act, 2018. Annual continuation

awards will depend on the availability of funds, recipient progress in meeting project goals and objectives, timely

submission of required data and reports, and compliance with all terms and conditions of award.

Contact information:

Program Issues

Joy Mobley, Psy.D. - Community Support Programs Branch

Division of Service and Systems Improvement - Center for Mental Health Services

(240) 276-2823

[email protected]





27


Gwendolyn Simpson - Office of Financial Resources - Division of Grants Management

(240) 276-1408

[email protected]

26. Targeted Capacity Expansion: Medication Assisted Treatment – Prescription

Drug and Opioid Addiction


FOA Number: TI-18-009 Application Due Date: Monday, July 9, 2018

Description: The purpose of this program is to expand/enhance access to medication-assisted treatment (MAT) services

for persons with an opioid use disorder (OUD) seeking or receiving MAT. This program’s focus is on funding

organizations and tribes/tribal organizations within states identified as having the highest rates of primary treatment

admissions for heroin and opioids per capita and includes those states with the most dramatic increases for heroin and

opioids, based on SAMHSA’s 2015 Treatment Episode Data Set (TEDS). The desired outcomes include: 1) an increase

in the number of individuals with OUD receiving MAT 3) a decrease in illicit opioid drug use and prescription opioid

misuse at six-month follow-up.

Eligibility:

Domestic states, political subdivisions within states, and public and private nonprofit organizations in states with

the highest rates of primary treatment admissions for heroin and opioids per capita and includes those with the

most dramatic increases for heroin and opioids, as identified by SAMHSA’s 2015 Treatment Episode Data Set

(TEDS).

Tribes/tribal organizations across the United States are also eligible to receive funding.

Anticipated Total Available Funding: $65,583,803 (At least $5 million will be awarded to federally recognized

American Indian/Alaska Native (AI/AN) tribes/tribal organizations) Anticipated Number of Awards: Up to 125

Anticipated Award Amount: Up to $524,670 per year Length of Project: Up to three years


Proposed budgets cannot exceed $524,670 in total costs (direct and indirect) in any year of the proposed project. Funding

estimates for this announcement are based on the Consolidated Appropriations Act, 2018. Annual continuation awards

will depend on the availability of funds, recipient progress in meeting project goals and objectives, timely submission of

required data and reports, and compliance with all terms and conditions of award.


Program Issues

Kim Thierry-English - Center for Substance Abuse Treatment, Division of Services Improvement

(240) 276-2907

[email protected]

Grants Management and Budget Issues Eileen Bermudez - Office of Financial Resources, Division of Grants Management

(240) 276-1412

[email protected]

Listing of Grant Drug-Treatment Related Postings through the U.S. Department of Health & Human Services Health

Resources & Services Administration





28

CURRENT FUNDING PROGRAMS THROUGH HRSA:

There are currently no funding programs offered through HRSA related to substance use disorder.

PAST FUNDING PROGRAMS THROUGH HRSA:

27. Rural Communities Opioid Response Program – Assisted Treatment Expansion

https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=b78be3df-ea8f-40b0-82b4-ba0c0857030c

Funding Opportunity Number: HRSA-19-102

Application Deadline: 06/18/2019 Projected Award Date: 09/01/2019

Program Description: This funding opportunity will advance RCORP’s overall goal by establishing and/or expanding

MAT in eligible hospitals, health clinics, or tribal organizations in high-risk rural communities. RCORP-MAT Expansion

aims to increase the number of access points where individuals living in rural communities with OUD can receive

evidence-based treatment. Additionally, recognizing that MAT patients may have other clinical and social service needs,

RCORP-MAT Expansion requires that eligible entities provide and/or coordinate complementary services (e.g., provision

of or referral to other SUD/OUD and mental health services, assistance with transportation, etc.), as outlined in the

Program-Specific Instructions section of this NOFO.

Additional Eligibility:

Eligible entities include critical access hospitals, rural health clinics, other small rural hospitals with 49 available staffed

beds or less, as reported on the hospital’s most recently filed Medicare Cost Report; Health Center Look Alikes; and tribes

or tribal organizations. Applicants must be located in a HRSA-designated rural area.


Kiley Diop

[email protected]

(301) 443-6666

28. Rural Communities Opioid Response Program – Rural Centers of Excellence on

Substance Use Disorders

https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=3df1746a-314c-4581-a570-940058b6b849



Program Description: The purpose of RCORP-RCOE is to support the identification, translation, dissemination, and

implementation of evidence-based programs and best practices “related to the treatment for and prevention of substance

use disorders within rural communities, with a focus on the current opioid crisis and developing methods to address future

substance use disorder epidemics.” 1) The Centers will engage in research to identify “science-based prevention,

treatment, and other risk reduction interventions, including community-based approaches that may be replicable in other

rural communities and associated professional training.” 2) After identifying rural-relevant interventions, the Centers will

serve as a resource for “scientific and technical assistance to county and state health departments and other entities as

identified seeking guidance on how to address the substance use disorder challenges in their community.” 3) Other such

https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=b78be3df-ea8f-40b0-82b4-ba0c0857030c

https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=3df1746a-314c-4581-a570-940058b6b849

29

entities in rural communities may include, but are not limited to, state offices of rural health (SORHs), critical access

hospitals (CAHs), rural health clinics (RHCs), and other rural health care providers. Training and technical assistance

(TA) should help rural communities translate best practices to their unique community settings and implement those

practices to reduce the morbidity and mortality related to SUD, particularly OUD, in their area. Over the three-year period

of performance, the Centers should demonstrate how scientific and technical assistance and professional training related

to evidence-based SUD interventions can improve prevention, treatment, and recovery in rural communities, with a focus

on OUD. The Centers should also demonstrate how their programming improves health and other outcomes as well as

systems for addressing current and future SUD epidemics in rural communities.


Eligible applicants include all domestic public or private, non-profit or for-profit entities, including state, county, or city

or township governments; independent school districts; public housing authorities or Indian housing authorities; public or

private institutions of higher education; small businesses; faith-based and community-based organizations; and federally

recognized tribes, tribal organizations, and tribal governments; or consortia of these organizations.


Aaron Beswick

[email protected]

(312) 353-7214

29. Fiscal Year (FY) 2019 Integrated Behavioral Health Services (IBHS)

https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=a238fc24-7a74-4c8f-8455-7b2e18e9e817



Program Description: This supplemental funding opportunity for existing Health Center Program (H80) award recipients

will increase access to high quality integrated behavioral health services, including prevention or treatment of mental

health conditions and/or substance use disorders, including opioid use disorder.


Organizations receiving Health Center Program operational grant (H80) funding at the time of this funding opportunity

release are eligible to apply.


Rael Ammon

[email protected]

(301) 594-4300

30. Opioid Workforce Expansion Program (OWEP) Paraprofessionals

https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=b46a08de-2bc2-421f-8b5e-71de9cc9b17d



Program Description: The purpose of this program is to enhance community-based experiential training for students

preparing to become peer support specialists and other types of behavioral health-related paraprofessionals with a focus

on Opioid Use Disorder (OUD) and other Substance Use Disorders (SUD) prevention, treatment and recovery services.

https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=a238fc24-7a74-4c8f-8455-7b2e18e9e817



30

Consistent with the statutory authority, applicants must also demonstrate a special focus on preservice or in-service

training of paraprofessional child and adolescent mental health workers to understand the specific concerns of children,

adolescents, and transitional-age youth in high need and high demand areas who are at risk for behavioral health

disorders. The program is designed to expand and improve direct access to quality treatment and foster an integrated

and/or interprofessional approach to address OUD and other SUD treatment emphasizing the role of the family and lived

experience of the consumer through academic, community and non-traditional community organization partnerships. The

program also supports career development in behavioral health for paraprofessional career progression as well as the

development of skills and expertise of staff, facilitators, and training instructors in prevention, treatment, and recovery

services of OUD and other SUDs. Award recipients will impact the behavioral health workforce by increasing the number

of behavioral health-related paraprofessionals and transforming integrated and interprofessional teams to effectively

prevent and treat OUD and other SUDs in community-based practices.


State-licensed mental health nonprofit and for-profit organizations. These organizations must be able to carry out

programs for pre-service or in-service training of paraprofessional child and adolescent mental health workers. These

programs can include occupations such as peer support specialist, peer support counselor, community health worker,

outreach worker, social services aide, substance abuse/addictions worker, youth worker, and promotor/a (for full list of

occupations see the definitions section). For the purpose of this NOFO, these organizations may include academic

institutions, including universities, community colleges and technical schools, which must be accredited by a nationally

recognized accrediting agency, as specified by the U.S. Department of Education. Tribal Organizations may apply for this

these funds, if otherwise eligible. In addition to the 50 states, eligible entities include the District of Columbia, Guam, the

Commonwealth of Puerto Rico, the Northern Mariana Islands, American Samoa, the U.S. Virgin Islands, the Federated

States of Micronesia, the Republic of the Marshall Islands, or the Republic of Palau.


Nicole M. Wilkerson

[email protected]

(301)443-6666

31. Opioid Workforce Expansion Program (OWEP) Professionals




Program Description: The purpose of this program is to enhance community-based experiential training for students

preparing to become behavioral health professionals with a focus on Opioid Use Disorder (OUD) and other Substance Use

Disorders (SUD) prevention, treatment, and recovery services. The program will provide funding for training behavioral

health professionals in the provision of OUD and other SUD prevention, treatment, and recovery services in high need

and high demand areas. The program also supports the development of behavioral health faculty skills and expertise in the

prevention, treatment, and recovery of patients with OUD and other SUD. Award recipients will impact the quality and

access to behavioral health and substance use services in high need and high demand areas by increasing the number of

professionals and transforming integrated behavioral health and primary care teams to effectively prevent and treat OUD

and other SUD in community-based practices.


Accredited institutions of higher education or accredited behavioral health professional training programs. These

programs can include psychiatry, psychology, school psychology, behavioral pediatrics, psychiatric nursing, social work,

school social work, SUD prevention and treatment, marriage and family therapy, occupational therapy, school counseling,

or professional counseling. To ensure students are prepared to enter the workforce immediately upon graduation,



31

programs must require a pre-degree clinical field placement in behavioral health as part of the training and a prerequisite

for graduation.

Accredited masters or doctoral-level programs in social work.

American Psychology Association (APA)-accredited doctoral, internship and post-doctoral residency programs of

psychology and health service psychology (including clinical psychology, counseling and school psychology)

programs in practice psychology.

Domestic faith-based and community-based organizations and tribal organizations are also eligible to apply, if

otherwise eligible.

In addition to the 50 states, eligible entities include the District of Columbia, Guam, the Commonwealth of Puerto

Rico, the Northern Mariana Islands, American Samoa, the U.S. Virgin Islands, the Federated States of

Micronesia, the Republic of the Marshall Islands, or the Republic of Palau.


Andrea G. Battle, Ph.D.

[email protected]

(301) 443-1928

32. Graduate Psychology Education (GPE) Program

https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=56c79f3f-e00c-453d-bed4-f4ae55aaf4bc



Program Description: The purpose of this program is to train doctoral health psychology students, interns, and post-

doctoral residents to provide integrated, interdisciplinary, behavioral health and Opioid Use Disorder (OUD) and other

Substance Use Disorder (SUD) prevention and treatment services in high need and high demand areas. The program also

supports faculty development of health service psychology. For purposes of this NOFO, high need and high demand areas

are identified by two defined sources:

County of experiential training site location has less than 10 licensed psychologists per 100,000 population as

found in the APA County Level Analysis of US Licensed Psychologists

Experiential training site is located in a Mental Health Professional Shortage Areas (HPSAs) or that are Facility

Mental HPSAs with a score of 16 or above as found in the HPSA Find Tool.

The overarching goal of the program is to prepare and build capacity of the doctoral health psychology workforce, to

provide mental/behavioral health care, including OUD and other SUD prevention and treatment services, in high need and

high demand areas.


Eligible entities are APA-accredited doctoral schools and programs of health service psychology, APA-accredited

doctoral internships in professional psychology, and APA-accredited post-doctoral residency programs in practice

psychology.


Andrea G. Battle, Ph.D.

[email protected]

(301) 443-1928

33. Rural Communities Opioid Response Program-Implementation

https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=7afdb9d3-f7e5-484a-9c91-618e809c6005


https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=56c79f3f-e00c-453d-bed4-f4ae55aaf4bc


https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=7afdb9d3-f7e5-484a-9c91-618e809c6005

32



Program Description: The Rural Communities Opioid Response Program (RCORP) is a multi-year opioid-focused

initiative by the Health Resources and Services Administration (HRSA) aimed at reducing the morbidity and mortality of

substance use disorder (SUD), including opioid use disorder (OUD), in rural communities at the highest risk for SUD.

This notice announces the opportunity to apply for funding under the RCORP-Implementation. RCORP-Implementation

will advance RCORP’s overall goal by strengthening and expanding SUD/OUD prevention, treatment, and recovery

service delivery in high-risk rural communities. By expanding the options for SUD/OUD services across the care

spectrum, RCORP-Implementation will help rural residents access treatment and move towards recovery. In 2017, the

U.S. Department of Health and Human Services (HHS) initiated a comprehensive effort to empower local communities to

combat the opioid crisis through a Five-Point Strategy. In alignment with the HHS Five-Point Strategy, and as part of

RCORP, RCORP-Implementation award recipients will implement robust, evidence-based interventions and promising

practice models to expand access to, and strengthen the quality of, SUD/OUD prevention, treatment, and recovery

services in high-risk rural communities.

You are required to align your application with the following RCORP-Implementation focus areas:

a. Prevention: Reducing the occurrence and associated risk of OUD among new and at-risk users (including

polysubstance users), as well as fatal opioid-related overdoses, and promoting infectious disease detection through

activities such as community and provider education, harm reduction strategies, and referral to treatment and

recovery support services.

b. Treatment: Implementing or expanding access to evidence-based practices, including medication-assisted

treatment (MAT) with psychosocial intervention, and eliminating or reducing treatment costs for uninsured and

underinsured patients.

c. Recovery: Implementing or expanding access to recovery and treatment options that help people battling OUD

(including those with polysubstance disorders) start and stay in recovery, including ensuring access to support

services such as, but not limited to, transportation, housing, peer recovery, case management, employment

assistance, and child care.

HRSA envisions that award recipients will sustain programs beyond the three-year period of performance. In particular, it

is expected that RCORP-Implementation award recipients will:

Leverage other available opioid resources at the federal, state and local levels to maximize program impact

Expand the ability of providers to bill for treatment services

Monitor and evaluate the impact and outcomes of SUD/OUD prevention, treatment, and recovery activities

Develop a long-term strategy to achieve financial and operational sustainability absent federal funding and

address the future needs of the community.

In FY 2019, HRSA will provide support for additional programs to improve access to prevention, treatment, and recovery

support services in rural communities, including additional RCORP-Planning grants and National Health Service Corps

(NHSC) Loan Repayment Program (LRP) awards.


Eligible applicants include all domestic public or private, non-profit or for-profit entities, including faith-based and

community-based organizations, tribes, and tribal organizations and should serve rural communities at the highest risk for

SUD. All activities supported by RCORP-Implementation must exclusively target populations residing in HRSA-

designated rural counties or rural census tracts in urban counties (as defined by the Rural Health Grants Eligibility

Analyzer). HRSA-19-082 4 The applicant organization may be located in an urban or rural area and should have the

staffing and infrastructure necessary to oversee program activities, serve as the fiscal agent for the award, and ensure that

local control for the award is vested in the targeted rural communities.

33


Allison Hutchings

[email protected]

(301) 945-9819

34. Rural Communities Opioid Response Program-Evaluation

https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=3928c5b9-8c40-45a7-81b2-88c835bc5e09



Program Description: The purpose of this cooperative agreement is to evaluate the impact of Rural Community Opioid

Response Program (RCORP) initiatives which currently include the RCORP-Planning, RCORP-Implementation, and

RCORP-Technical Assistance (RCORP-TA) activities, and to develop valuable RCORP-based evaluation tools and

resources for use in rural communities and to inform future rural health initiatives. Working with all RCORP award

recipients, the RCORP-Evaluation anticipated activities include collecting and analyzing award recipient-reported data,

defining and implementing impact indicators to assess the effectiveness of TA and award recipient activities, working

with the RCORP-TA provider to identify RCORP best practices, using RCORP findings to identify research needs, and

making recommendations to enhance RCORP activities and inform future rural health initiatives.


Eligible applicants include domestic public or private, non-profit or for-profit organizations. Institutions of higher

education, faith-based and community-based organizations, tribes, and tribal organizations are eligible to

apply. Applicants may be a single entity or a consortium.


Fraser Byrne

[email protected]

(301) 443-2299

35. Small Health Care Provider Quality Improvement Program

https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=00ba519a-3f47-4987-99ba-b1d443cf8097



Program Description: The purpose of the Rural Quality Program is to support planning and implementation of quality

improvement activities for rural primary care providers or providers of health care services, such as a critical access

hospital or a rural health clinic, serving rural residents. These activities include providing clinical health services to

residents of rural areas by funding projects that coordinate, expand access, contain costs, and improve the quality of

essential health care services. The program goal is to promote the development of an evidence-based quality improvement

culture and to promote the delivery of cost-effective, coordinated health care services in primary care settings.

Successfully funded projects will enhance the delivery of health care in rural areas and demonstrate improvements in:

1) Patient health outcomes for the rural communities served

2) The delivery and quality of essential rural health care services by the end of the three-year period of

performance.


https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=3928c5b9-8c40-45a7-81b2-88c835bc5e09


https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=00ba519a-3f47-4987-99ba-b1d443cf8097

34

Additional objectives of the program include enhanced chronic disease management and increased engagement of patients

and their caregivers. The FY 2019 Rural Quality Program additionally requests project proposals focus on rural chronic

disease management and/or the integration of mental/behavioral health services into the rural primary care setting.

Although it is not a requirement, HRSA strongly encourages applicants to form a consortium or network for this program.

Awarded organizations are not required to, but are permitted, to use funds to obtain or maintain nationally recognized.


Eligible applicants must be a rural public or rural nonprofit private health care provider or provider of health care services,

such as a critical access hospital or a rural health clinic; or network of small rural providers; and must not previously have

received an award under this subsection for the same or similar project. For the purposes of this program, “health care

provider” may include, but is not limited to, entities such as black lung clinics, hospitals, public health agencies, home

health providers, mental health centers and providers, substance abuse service providers, rural health clinics, primary care

providers, oral health providers, social service agencies, health profession schools, local school districts, emergency

services providers, community health centers/federally qualified health centers, tribal health programs, churches, and civic

organizations that are providing health care services.


Katherine Lloyd

[email protected]

(301) 443-2933

36. Strengthening Systems of Care for People Living with HIV and Opioid Use

Disorder

https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=e10984ec-f552-4caf-a3b4-0283d5470520



Program Description: The purpose of this initiative is to fund an estimated one (1) to four (4) entities, referred to as

System Coordination Providers (SCPs), who will assist states in leveraging resources at federal, state, and local levels for

people living with HIV (PLWH) and opioid use disorder (OUD). Specifically, the goal of this initiative is to strengthen

system-level coordination and networks of care between the Ryan White HIV/AIDS Program (RWHAP) recipients and

other federal, state and local entities funded to respond to the opioid epidemic to ensure PLWH and OUD have access to

behavioral health (BH) care, treatment, and recovery services.

This will be accomplished by identifying new and expanded resources to treat persons with OUD, identifying new and

existing partners in the system of care, and building and strengthening networks of care between the RWHAP and entities

receiving OUD-focused resources. This initiative will strengthen and build upon existing systems of care and treatment

that will maximize cross-sector collaboration across federal, state, and local partners in order to achieve improvements in

the system-level coordination and leveraging of available resources for improving the health outcomes of PLWH and

OUD.

The SCP(s) awarded under this initiative will be responsible for implementing a system-wide assessment of OUD care

and treatment, if none is available, and identifying the availability of resources at the federal, state, and local levels to

combat the national opioid epidemic. The SCP(s) will assist RWHAP providers in leveraging the use of these resources

for the care and treatment of OUD in PLWH, and should capitalize on what has already been done, if relevant. The

SCP(s) will ultimately enhance the capacity of these organizations to capitalize on resources directed at addressing the

opioid epidemic to improve BH treatments among PLWH and OUD.


https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=e10984ec-f552-4caf-a3b4-0283d5470520

35


Entities eligible for funding under Parts A – D of Title XXVI of the Public Health Service Act as amended by the Ryan

White HIV/AIDS Treatment Extension Act of 2009, including public health departments and institutions of higher

education, state and local governments, nonprofit organizations, faith-based and community-based organizations, tribes

and tribal organizations are eligible to apply.


Adan Cajina

[email protected]

(301) 443-3180

37. Rural Residency Planning and Development Program

https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=bd0f561a-78b7-4053-a06f-722afa117f31



Program Description: The purpose of this grant program is to develop new rural residency programs or Rural Training

Tracks (RTT) in family medicine, internal medicine, and psychiatry, to support expansion of the physician workforce in

rural areas. The new rural residency programs or RTTs are intended to be sustainable through separate public or private

funding beyond the RRPD grant period of performance.

Rural residency programs are allopathic and osteopathic physician residency training programs that primarily train in rural

communities, place residents in rural locations for greater than 50 percent of their training, and focus on producing

physicians who will practice in rural communities. A common model is the RTT, where the first year of training occurs

within a larger program in an urban academic medical center and the final two years occur in a rural facility.


Eligible applicants are: 1) rural hospitals, 2) rural community-based ambulatory patient care centers, including federally

qualified health centers, community mental health centers or rural health clinics, 3) health centers operated by the Indian

Health service, an Indian tribe or tribal organization, or an urban Indian organization; 4) schools of allopathic medicine or

osteopathic medicine, 5) public or private non-profit graduate medical education consortiums 6) entities such as faith-

based and community-based organizations, capable of carrying out the grant activities.

If the applicant’s sustainability plan is to obtain Medicare graduate medical education payments, the applicant

organization must be a rural hospital in accordance with Medicare regulations. Eligible applicants must be located in a

rural location. In the case of a consortium, a school of allopathic medicine or osteopathic medicine, or other public or non-

profit entity, eligible applicants must have a primary training partner (where resident training will occur primarily or

exclusively) located in a rural area.


Tracey Smith

[email protected]

(301) 443-3612

38. Rural Health Innovation and Transformation Technical Assistance

https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=5fbf826f-13dd-4dd2-95b7-f15151fd5599



https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=bd0f561a-78b7-4053-a06f-722afa117f31


https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=5fbf826f-13dd-4dd2-95b7-f15151fd5599

36


Program Description: The purpose of this program is to provide technical assistance (TA) to rural stakeholders and the

public to help them understand and engage in the value-based care landscape in the context of rural health care.

In an effort to control health care costs and improve the quality of care, public and private payers have increasingly

implemented initiatives to encourage value-based care. Value-based care programs reward health care providers for the

quality of care through the realignment of financial incentives towards value over volume. Because of the unique

economic factors affecting rural providers, the implementation and effects of value-based care initiatives may look

different in rural, low-volume settings. For example, low patient volumes, along with low margins, in rural settings can

make it more difficult to absorb the financial risks associated with value-based care. Start-up costs for value-based care

may seem prohibitive for some, while small volumes may make it more difficult to measure value and may increase the

risk of skewed outcomes. At the same time, value-based care initiatives are evolving towards risk-based models, and there

is a need to help stakeholders and the public understand how these changes affect rural health care. Therefore, a major

goal of this funding opportunity is to support the ability of rural providers to participate and succeed in current and

emerging payment and delivery system models designed to provide value-based care.


Eligible applicants include domestic public, private, and non-profit organizations, including tribes and tribal

organizations, and domestic faith-based and community-based organizations


Kerri Cornejo

[email protected]

(301) 443-4204

39. U3D Maternal and Child Health Measurement Research Network (MRN)

https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=ad02b5d6-6f67-4f0b-b8a5-b5d89492fb11



Program Description: The purpose of this program is to coordinate a national platform to recruit, convene, and actively

engage researchers and family members to identify and fill gaps in existing MCH measures. This national MRN is an

interdisciplinary Research Network focused on supporting, optimizing, and centralizing MCH-related health measurement

research (hereafter referred to as “the Network”).

The Network should prioritize the identification, development, dissemination, and cross disciplinary adoption of measures

to address gaps in the following topical areas: family engagement, adequacy of pediatric health care utilization,[1] parent-

infant dyadic relational health,[2] positive child health and wellbeing,[3] and measures related to maternal morbidity and

mortality.[4] Reliable, validated measures on these topical areas are important in addressing health disparities and

improving health outcomes for MCH populations. The Network should incorporate relevant HRSA priorities that are

aligned with Title V Maternal and Child Health Block Grant national performance measures, including opioid and

substance use disorder, mental health, maternal morbidity/mortality, and/or childhood obesity. The Network should

provide quantifiable evidence and metrics demonstrating the adoption of the developed and/or validated measures by

diverse stakeholders.


Eligible applicants include domestic public or non-profit institutions of higher learning and public or private non-profit

agencies engaged in research or in programs relating to maternal and child health and/or services for children with special


https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=ad02b5d6-6f67-4f0b-b8a5-b5d89492fb11

37

health care needs are eligible to apply. Domestic faith-based and community-based organizations, tribes, and tribal

organizations are also eligible to apply, if they otherwise meet these eligibility criteria.


Evva Assing-Murray, Ph.D., MA

[email protected]

(301) 594-4113

40. Small Rural Hospital Improvement Program

https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=c373380d-bd12-47d7-82b4-6c0466b5c766



Program Description: This notice announces the opportunity to apply for funding under the Small Rural Hospital

Improvement Program (SHIP). This program supports eligible hospitals in meeting value-based payment and care goals

for their respective organizations, through purchases of hardware, software and training. SHIP also enables small rural

hospitals: to become or join accountable care organizations (ACOs); to participate in shared savings programs; and to

purchase health information technology (hardware and software), equipment, and/or training to comply with quality

improvement activities, such as advancing patient care information, promoting interoperability, and payment bundling.


The SORH will be the official award recipient acting as fiscal intermediary for all hospitals within its state. Eligible

applicants include states that are currently SHIP recipients, as well as states with hospitals that meet eligibility

requirements yet have not been previously funded. SHIP funds assist eligible small rural hospitals that are essential access

points for Medicare and Medicaid beneficiaries. Eligible small rural hospitals are non-federal, short-term general acute

care facilities that are located in a rural area of the U.S. and the territories, including faith-based hospitals.

For the purpose of this program: 1) "eligible small rural hospital" is defined as a non-federal, short-term general acute care

hospital 2) "rural area" is defined as either located outside of a Metropolitan Statistical Area, located within a rural census

tract of a MSA, or is being treated as if being located in a rural area 3) Eligible SHIP hospitals may be for-profit or not-

for-profit, including faith-based.


Jeanene Meyers

[email protected]

(301) 443-2482

41. Rural Health Network Development Planning Program

https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=820ff0a2-594f-4944-81b4-54365531cab1



Program Description: The purpose of the Network Planning program is to assist in the development of an integrated

health care network, specifically network participants who do not have a history of formal collaborative efforts in order to:

https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=c373380d-bd12-47d7-82b4-6c0466b5c766


https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=820ff0a2-594f-4944-81b4-54365531cab1

38

(i) achieve efficiencies; (ii) expand access to, coordinate, and improve the quality of essential health care services; and

(iii) strengthen the rural health care system as a whole.


The applicant organization must be a rural nonprofit private or rural public entity that represents a consortium/network

composed of three or more health care providers. Federally-recognized tribal entities are eligible to apply as long as they

are located in a rural area. The applicant organization must be located in a non-metropolitan county or in a rural census

tract of a metropolitan county, and all services must be provided in a non-metropolitan county or rural census tract.


Sara Afayee

[email protected]

(301) 945-4169

42. Rural Communities Opioid Response Program – Technical Assistance

https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=35ee358e-d42f-4c7a-ba6e-d71f228eb1a9

Funding Opportunity Number: HRSA-18-124 Application Deadline: 08/10/2018

Description: The purpose of this cooperative agreement is to provide technical assistance (TA) support for rural

communities engaging in activities to combat opioid use disorder (OUD). The TA efforts will enhance the organizational

and infrastructural capacity of multi-sector consortiums at the community, county, state, and/or regional levels. The

overall goal is the reduction of morbidity and mortality associated with opioid overdoses in high-risk rural communities.

The RCORP -TA award recipient will provide resources and expertise in support of the execution of the following focus

areas:

Prevention: reducing the occurrence of OUD among new and at-risk users as well as fatal opioid-related

overdoses through community and provider education and harm reduction measures including the strategic

placement of overdose reversing devices, such as naloxone;

Treatment: implementing or expanding access to evidence-based practices for opioid addiction/OUD treatment

such as medication-assisted treatment (MAT), including developing strategies to eliminate or reduce treatment

costs to uninsured and underinsured patients

Recovery: expanding peer recovery and treatment options to help people start and stay in recovery.

The RCORP-TA initiative is part of a multi-year, $130.0 million opioid focused effort by HRSA that will include:

improving access to and recruitment of new substance use disorder providers; building sustainable treatment resources;

increasing the use of telehealth; establishing cross-sector community partnerships; implementing new models of care,

including integrated behavioral health; and providing technical assistance. The RCORP -TA award recipient will provide

in-depth TA for planning and implementation to HRSA’s Rural Communities Opioid Response Program award recipients.

In FY 2019 and beyond, there will be additional funds available to provide continued support, including additional grants

and National Health Service Corps (NHSC) Loan Repayment Program awards. RCORP award recipients and the

communities they serve will receive tailored TA that may include, but is not limited to, the following:

Developing and implementing a strategic plan for the provision of TA to consortiums that are funded by HRSA

through the RCORP grants

Synthesizing resources for the development and strengthening of consortiums; HRSA-18-124 2

Developing training and tools to support analysis of opportunities and gaps in the workforce and service delivery

(to include telehealth) associated with OUD prevention, treatment, and recovery

Developing training and tools to educate RCORP award recipients and facilitate their strategic plan development

addressing gaps in OUD prevention, treatment, and recovery

Identifying and developing training and tools associated with workforce recruitment and retention targeted to

rural communities to build provider capacity to address OUD issues


39

Assisting RCORP award recipients in collaborating with the National Health Service Corps (NHSC) to recruit

providers

Assisting with the identification and development of evidence-based practice models relating to OUD prevention,

treatment, and recovery

Assisting with the identification and development of sustainability practices for consortiums

Assisting with the identification and development of program measures for award recipients for the RCORP

grants

Assisting in building consortiums’ capacity and infrastructure to collect data to participate in program-wide

evaluation activities

Educating RCORP award recipients about other available federal and non-federal funding and resources to

prepare them to leverage those resources, aid coordination, and avoid duplication of program efforts

Educating rural stakeholders of national and state laws associated with OUD prevention,

Additional Eligibility: Eligible applicants include domestic public or private, non-profit entities. Domestic faith-based

and community-based organizations, tribes, and tribal organizations are also eligible to apply.


Michael McNeely

[email protected]

(301) 443-5812

43. Rural Communities Opioid Response Program - Planning

https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=35ee358e-d42f-4c7a-ba6e-d71f228eb1a9

Funding Opportunity Number: HRSA-18-116 Application Deadline: 08/03/2018

Description: This notice solicits applications for the Rural Communities Opioid Response Program- Planning (RCORP-

Planning). The purpose of RCORP is to support treatment for and prevention of substance use disorder, including opioid

use disorder, in rural counties at the highest risk for substance use disorder, including the 220 counties identified by the

Centers for Disease Control and Prevention (CDC) as being at risk for HIV and Hepatitis C infections due to injection

drug use (See Appendix A for additional eligibility information).

Additional Eligibility: Eligible applicants include all domestic public or private, non-profit or for-profit, entities,

including faith-based and community-based organizations, tribes, and tribal organizations, who will serve rural

communities at the highest risk for substance use disorder and who meet the RCORP-Planning specifications for the

Applicant Organization and Consortium as described below.


Allison Hutchings

[email protected]

(301) 945-9819

CURRENT FUNDING PROGRAMS THROUGH NATIONAL INSTITUTE OF

HEALTH:

44. NIDA Research Center of Excellence Grant Program (P50 Clinical Trial

Optional)

https://grants.nih.gov/grants/guide/pa-files/PAR-19-259.html




40

FOA: PAR-19-259 Application Due Date: January 7, 2022

Description: The purpose of this FOA is to provide support for research Centers that (1) conduct drug abuse and

addiction research in any area of NIDA’s mission, (2) have outstanding innovative science, (3) are multidisciplinary,

thematically integrated, synergistic, and (4) serve as national resource(s) to provide educational and outreach activities to

drug abuse research communities, educational organizations, the general public, and policy makers in the NIDA research

fields. It is expected that a Center will transform knowledge in the sciences it is studying. Incremental work should not be

the focus of Center activities; rather, new and creative directions are required. The P50 Center of Excellence is expected

to foster the career development and mentoring of new investigators who would be given meaningful roles to play in the

Center projects. A goal of this program is to create NIDA Centers that are national community resources for furthering

drug abuse research by sharing their findings, their data, and their resources as appropriate for researchers to use and build

upon and to advance research in this field.

Eligibility: Higher education institutions, nonprofits other than institutions of higher education, for-profit organizations,

governments, and others (all of which are more specifically defined under Section III part 1 of the full text announcement)

Award Information: Budgets for direct costs cannot exceed $10,000,000 for the entire 5 year project period including no

cost extensions, but need to reflect the actual needs of the proposed project. The maximum project period is 5 years.


Scientific/Research Contact

Kevin Walton, Ph.D.

NIDA

301-435-0762

[email protected]

Meyer D. Glantz, Ph.D.

NIDA

301-443-6504

[email protected]

Roger Little, Ph.D.

NIDA

301-435-1316

[email protected]

Steven Grant, Ph.D.

NIDA

301-443-4877

[email protected]

Peer Review Contact

Gerald McLaughlin, Ph.D.

NIDA

301-827-5819

[email protected]

Financial/Grants Management Contact

Cheryl Nathaniel

NIDA

202-526-5819

[email protected]

45. Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses:

Epidemiology and Prevention (R03 - Clinical Trial Optional)










41

Description: The purpose of this FOA is to encourage research grant applications that explore whether and how alcohol

and other illicit drugs or illicitly used prescription drugs interact to contribute to unintentional injuries and poisonings and

how to prevent and/or reduce simultaneous use of alcohol or drugs singly or in combination.


governments, other, and certain foreign institutions (all of which are more specifically defined under Section III part 1 of

the full text announcement)

Award Information: Budgets are limited to $50,000 in direct costs per year. The total project period may not exceed two

years.



Robert Freeman, Ph. D. (for overdose projects)

NIAAA

301-443-8820

[email protected]

Gregory Bloss (for traffic safety projects)

NIAAA

301-443-3865

[email protected]

Marsha Lopez, Ph.D. (for projects intended as NIDA submissions)

NIDA

301-402-1846

[email protected]

Peer Review Contact

Examine your eRA Commons account for review assignment and contact information (information appears two weeks

after the submission due date).


Judy Fox

NIAAA

301-443-4707

[email protected]

Jennifer Schermerhorn

NIDA

301-827-6704

[email protected]

46. Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial

Optional)


FOA: PAR-19-064 Application Due Date: November 8, 2021

Description: This FOA will support pilot, feasibility or exploratory research in 5 priority areas in substance use

epidemiology and health services, including: 1) responses to sudden and severe emerging drug issues (e.g. the ability to

look into a large and sudden spike in opioid or synthetic cannabinoid use/overdoses in a particular community); 2)

responses to emerging marijuana trends and topics related to the shifting policy landscape; 3) responses to unexpected and

time-sensitive prescription drug abuse research opportunities (e.g., new state or local efforts); 4) responses to unexpected

and time-sensitive medical system issues (e.g. opportunities to understand addiction services in the evolving health care

system); and 5) responses to unexpected and time-sensitive criminal or juvenile justice opportunities (e.g. new system

and/or structural level changes) that relate to drug abuse and access and provision of health care service. It should be clear

that the knowledge gained from the proposed study is time-sensitive and that an expedited rapid review and funding are

required in order for the scientific question to be answered (i.e. an imminent policy change will not allow for standard

review and funding timeline).







42



Award Information: Direct costs are limited to $275,000 over a two-year project period. No more than $200,000 may be

requested in any single year. The maximum project period is 2 years.



Kelly D. Blake, Sc.D.

NCI

240-281-5934

[email protected]

Marsha Lopez, Ph.D., MHS

NIDA

301-443-6504

[email protected]

Peer Review Contact


NIDA

301-827-5819

[email protected]


Crystal Wolfrey

NCI

240-276-6277

[email protected]


NIDA

301-451-2649

[email protected]

47. HEAL Initiative: America’s Startups and Small Businesses Build Technologies to

Stop the Opioid Crisis (R43/R44 - Clinical Trial Optional)

https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-19-019.html

FOA: RFA-DA-19-019 Application Due Date: September 8, 2021

Description: This FOA invites eligible United States small business concerns (SBCs) to submit Small Business

Innovation Research (SBIR) grant applications to develop technologies to provide science- and research-based solutions

to the national opioid emergency and offer new hope for individuals, families, and communities affected by this

devastating crisis. United States SBCs that have the research capabilities and technological expertise to contribute to

NIDA R&D mission identified in this FOA are encouraged to submit SBIR grant applications in response to the FOA

topics.

Eligibility: Only United States small business concerns (SBCs) are eligible to submit applications for this opportunity.

Award Information: According to statutory guidelines, total funding support (direct costs, indirect costs, fee) normally

may not exceed $150,000 for Phase I awards and $1,000,000 for Phase II awards. With appropriate justification from the

applicant, Congress will allow awards to exceed these amounts by up to 50% as a hard cap ($225,000 for Phase I and

$1,500,000 for Phase II). However, NIH has received a waiver from SBA, as authorized by statute, to exceed the hard cap

of $225,000 for Phase I or $1,500,000 for Phase II for specific topics. The current list of approved topics can be found

at https://sbir.nih.gov/funding#omni-sbir. Applicants are strongly encouraged to contact NIH program officials prior to

submitting any application in excess of the guidelines and early in the application planning process. In all cases,

applicants should propose a budget that is reasonable and appropriate for completion of the research project. Award

periods normally may not exceed 6 months for Phase I and 2 years for Phase II. Applicants are encouraged to propose a

project duration period that is reasonable and appropriate for completion of the research project.







https://sbir.nih.gov/funding#omni-sbir

43



Elena Koustova, Ph.D., MBA

NIDA

301-496-8768

[email protected]

Lili Portilla, MPA

NCATS

301-827-7170

[email protected]

Peer Review Contact


NIDA

301-827-5819

[email protected]


Amy Connolly

NIDA

301-827-4457

[email protected]

Artisha Eatmon

NCATS

301-594-3028

[email protected]

48. HEAL Initiative: America’s Startups and Small Businesses Build Technologies to

Stop the Opioid Crisis (R41/R42 - Clinical Trial Optional)


FOA: RFA-DA-19-020 Application Due Date: September 8, 2021

Description: This FOA invites eligible United States small business concerns (SBCs) to submit Small Business

Technology Transfer (STTR) grant applications to develop technologies to provide science- and research-based solutions

to the national opioid emergency and offer new hope for individuals, families, and communities affected by this

devastating crisis. United States SBCs that have the research capabilities and technological expertise to contribute to

NIDA R&D mission identified in this FOA are encouraged to submit STTR grant applications in response to the FOA

topics.

Eligibility: Only United States small business concerns (SBCs) are eligible to submit applications for this opportunity.

Award Information: According to statutory guidelines, total funding support (direct costs, indirect costs, fee) normally

may not exceed $150,000 for Phase I awards and $1,000,000 for Phase II awards. With appropriate justification from the

applicant, Congress will allow awards to exceed these amounts by up to 50% as a hard cap ($225,000 for Phase I and

$1,500,000 for Phase II). However, NIH has received a waiver from SBA, as authorized by statute, to exceed the hard cap

of $225,000 for Phase I or $1,500,000 for Phase II for specific topics. The current list of approved topics can be found

at https://sbir.nih.gov/funding#omni-sbir. Applicants are strongly encouraged to contact NIH program officials prior to

submitting any application in excess of the guidelines and early in the application planning process. In all cases,

applicants should propose a budget that is reasonable and appropriate for completion of the research project.

Award periods normally may not exceed 1 year for Phase I and 2 years for Phase II. Applicants are encouraged to propose

a project duration period that is reasonable and appropriate for completion of the research project.



Elena Koustova, Ph.D., MBA

NIDA

301-496-8768

[email protected]

Lili Portilla, MPA

NCATS

301-827-7170

[email protected]







https://sbir.nih.gov/funding#omni-sbir



44

Peer Review Contact


NIDA

301-827-5819

[email protected]


Amy Connolly

NIDA

301-827-4457

[email protected]

Shannon Oden

NIDA

301-594-3028

[email protected]




FOA: PAR-18-863 Application Due Date: September 7, 2021







Award Information: Budgets are not limited but need to reflect the actual needs of the proposed project. The total

project period may not exceed five years.




NIAAA

301-443-8820

[email protected]


NIAAA

301-443-3865

[email protected]


NIDA

301-402-1846

[email protected]

Peer Review Contact




Judy Fox

NIAAA

301-443-4707

[email protected]


NIDA

301-827-6704

[email protected]










45




FOA: PAR-18-862 Application Due Date: September 7, 2021







Award Information: The combined budget for direct costs for the two-year project period may not exceed $275,000. No

more than $200,000 may be requested in any single year. The total project period may not exceed two years.




NIAAA

301-443-8820

[email protected]


NIAAA

301-443-3865

[email protected]


NIDA

301-402-1846

[email protected]

Peer Review Contact

Ranga Srinivas, Ph.D.

NIAAA

301-451-2067

[email protected]


Judy Fox

NIAAA

301-443-4707

[email protected]


NIDA

301-827-6704

[email protected]

51. NIDA Research Education Program for Clinical Researchers and Clinicians (R25

Clinical Trial Not Allowed)


FOA: PAR-19-258 Application Due Date: July 22, 2021

Description: This FOA is intended to support research education activities that enhance the knowledge of substance use

(SU) and substance use disorder (SUD) research. The program is intended for those in clinically focused careers and/or









46

those training for careers as clinicians/health service providers, clinical researchers, or optimally a combination of the two.

This mechanism may not be used to support non-research-related clinical training.




Award Information: Budget requests may not exceed $350,000 in direct costs annually. The total project period may not

exceed five years.



Belinda E. Sims, Ph.D.

Division of Epidemiology, Services and Prevention

Research

NIDA

301-402-1533

[email protected]

Guifang Lao, Ph.D.

Division of Therapeutics and Medical Consequences

NIDA

301-443-6173

[email protected]

Yu (Woody) Lin, M.D., Ph.D.

Integrative Neuroscience Branch – Division of

Neuroscience and Behavioral Research

NIDA

301-435-1318

[email protected]

Beth Babecki, M.A.

Coordinator, Training Hub - Division of Neuroscience

and Behavioral Research

NIDA

301-827-5783

[email protected]

Flair Lindsey

Office of Research Training

NIDA

301-827-5783

[email protected]

Peer Review Contact


NIDA

301-827-5819

[email protected]


Pam Fleming

NIDA

301-443-6710

[email protected]

52. Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol,

and Tobacco Use Disorders (R34 Clinical Trial Optional)


FOA: PAR-18-774 Application Due Date: May 7, 2021









47

Description: This FOA encourages pilot and preliminary research in preparation for larger-scale services research

effectiveness trials. Relevant trials may test a wide range of approaches, including interventions, practices, and policies

designed to optimize access to, and the quality, effectiveness, affordability and utilization of drug, tobacco, or alcohol use

disorder treatments and related services, as well as services for comorbid medical and mental disorder conditions.

Relevant approaches may include both those that are novel, and those that are commonly used in practice but lack an

evidence base. This FOA provides resources for assessing the feasibility, acceptability, and utility of these approaches, in

addition to usual trial preparation activities.




Award Information: Direct costs are limited to $450,000 over the 3-year project period, with no more than $225,000 in

direct costs allowed in any single year. The total project period may not exceed three years.



Sarah Q. Duffy, Ph.D.

NIDA

301-451-4998

[email protected]

Lori Ducharme, Ph.D.

NIAAA

301-443-4715

[email protected]

Peer Review Contact




Amy Connolly

NIDA

301-827-4457

[email protected]

53. Pilot and Feasibility Studies in Preparation for Drug and Alcohol Abuse

Prevention Trials (R34 Clinical Trial Optional)



Description: This FOA for R34 applications seeks to support: (a) pilot and/or feasibility testing of innovative new,

revised, or adapted prevention intervention approaches to prevent or delay the initiation and onset of drug and alcohol use,

the progression to misuse or problem use or alcohol and other substance use disorder, reduce drinking and driving and

deaths related to impaired driving, prevent suicide attempts (nonfatal and fatal), and the drug- or alcohol-related

acquisition or transmission of HIV infection and viral hepatitis among diverse populations and settings; and, (b) pre-trial

feasibility and acceptability testing for prevention services and systems research. It is expected that research conducted via

this mechanism will consist of studies that are a pre-requisite for preparing and submitting subsequent applications for

larger scale drug or alcohol abuse prevention and/or drug- or alcohol-related HIV prevention intervention studies. This

FOA does not support applications for which the sole focus is development of intervention protocols, manuals, or the

standardization of protocols. Any intervention development work must be imbedded within a pilot/feasibility study. Of

particular interest is prevention research that addresses current public health priorities and priority settings and systems.





48




Award Information: $450,000 in direct costs over three years. No more than $225,000 in direct costs can be used in any

single year. The total project period may not exceed three years.



Jacqueline Lloyd, Ph.D., MSW

NIDA

301-443-8892

[email protected]

Beverly Ruffin, Ph.D.

NIAAA

301-443-0281

[email protected]

Peer Review Contact




Edith Davis

NIDA

301-827-6697

[email protected]

Judy Fox

NIAAA

301-443-4704

[email protected]

54. Multi-Site Studies for System-Level Implementation of Substance Use Prevention

and Treatment Services (R01 Clinical Trial Optional)



Description: The purpose of this FOA is to support the development and testing of interventions, models, and/or

frameworks that examine system-level implementation of evidence-based interventions, guidelines, or principles to

improve the delivery, uptake, quality, and sustainability of substance use prevention and treatment interventions and

services.



Award Information: Budgets are limited to $500,000 in direct costs in any project year, and need to reflect the actual

needs of the proposed project. The total project period may not exceed five years.



Tisha Wiley, Ph.D.

NIDA

301-594-4381

[email protected]


NIAAA

301-451-8507

[email protected]

Glen D. Morgan, Ph.D.

NCI

240-276-6787

[email protected]









49

Peer Review Contact


NIDA

301-827-5819

[email protected]


Maryellen Connell

NIDA

301-827-6695

[email protected]

Judy Fox

NIAAA

301-443-4704

[email protected]

Carol Perry

NCI

240-276-6282

[email protected]

55. Multi-Site Pilot & Feasibility Studies for System-Level Implementation of

Substance Use Prevention and Treatment Services (R34 Clinical Trial Optional)



Description: The purpose of this FOA is to support the development and testing of interventions, models, and/or

frameworks that examine system-level implementation of evidence-based interventions, guidelines, or principles to

improve the delivery, uptake, quality, and sustainability of substance use prevention and treatment interventions and

services.



Award Information: The combined budget for direct costs for the three year project period may not exceed $450,000.

No more than $225,000 may be requested in any single year. The total project period may not exceed three years.



Tisha Wiley, Ph.D.

NIDA

301-594-4381

[email protected]


NIDA

301-451-8507

[email protected]

Peer Review Contact


NIDA

301-827-5819

[email protected]


Maryellen Connell

NIDA

301-827-6695

[email protected]










50

Judy Fox

NIAAA

301-443-4704

[email protected]

56. Addressing the Challenges of the Opioid Epidemic in Minority Health and Health

Disparities Research in the U.S. (R21 Clinical Trial Optional)

http://grants.nih.gov/grants/guide/pa-files/PAR-18-745.html


Description: The purpose of this Funding Opportunity Announcement (FOA) is to encourage developmental and

exploratory research focused on determining the mechanisms for the variation in the prevalence of Opioid Use Disorder

(OUD), and understanding and reducing disparities in opioid care in minority health and health disparity populations in

the U.S. This initiative will also seek to identify multi-level intervention strategies at the institutional and systems level

for addressing OUD in these populations.

Eligibility: Small businesses, City or township governments, County governments, Native American tribal organizations

(other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than

institutions of higher education, For profit organizations other than small businesses, Special district governments,

Public and State controlled institutions of higher education, Public housing authorities/Indian housing authorities,

Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Others (see text

field entitled "Additional Information on Eligibility" for clarification), Native American tribal governments (Federally

recognized), State governments, Private institutions of higher education, and Independent school districts.

Award Information: The combined budget for direct costs for the two year project period may not exceed $275,000. No

more than $200,000 may be requested in any single year. The total project period may not exceed two years.



Andrew Louden, Ph.D. Benyam Hailu, M.D., M.P.H.

NIMHD NIMHD

301-594-9009 301-594-8696

[email protected] [email protected]

Judith A. Arroyo, Ph.D. Victoria Cargill

National Institute on Alcohol Abuse and Alcoholism Office of Research in Women’s Health (ORWH)

301-402-0717 301-435-0971


Sarah Duffy Rosemary D. Higgins, MD

NIDA NICHD

301-443-6504 301-435-7909


Amelia Karraker, Ph.D.

National Institute on Aging (NIA)

301-496-3131

[email protected]

Peer Review Contact

Weijia Ni, Ph.D

Center for Scientific Review (CSR)

301-594-3292/[email protected]










51


Priscilla Grant, J.D. Bryan Clark, MBA

NIMHD NICHD

301-594-8412 301-435-6975


Amy Connolly Judy Fox

NIDA NIAAA

301-827-4457 301-443-4704


57. Addressing the Challenges of the Opioid Epidemic in Minority Health and Health

Disparities Research in the U.S. (R01 Clinical Trial Optional)



Description: This funding opportunity announcement (FOA) seeks to support investigative and collaborative research

focused on determining the mechanisms for the variation in the prevalence of Opioid Use Disorder (OUD), and

understanding and reducing disparities in opioid care in minority health and health disparity populations in the U.S. This

initiative will also seek to identify multi-level intervention strategies at the institutional and systems level for addressing

OUD in these populations.

Eligibility: For profit organizations other than small businesses, Nonprofits that do not have a 501(c)(3) status with the

IRS, other than institutions of higher education, Small businesses, Native American tribal governments (Federally

recognized), Private institutions of higher education, County governments, Independent school districts, Nonprofits

having a 501(c)(3) status with the IRS, other than institutions of higher education, Public housing authorities/Indian

housing authorities, City or township governments, Native American tribal organizations (other than Federally recognized

tribal governments), State governments, Others (see text field entitled "Additional Information on Eligibility" for

clarification), Public and State controlled institutions of higher education, and Special district governments

Award Information: Application budgets are not limited but need to reflect the actual needs of the proposed project.

The scope of the proposed project should determine the project period. The maximum project period is 5 years.



Andrew Louden, Ph.D. Benyam Hailu, M.D., M.P.H.

NIMHD NIMHD

301-594-9009 301-594-8696


Judith A. Arroyo, Ph.D. Victoria Cargill

National Institute on Alcohol Abuse and Alcoholism Office of Research in Women’s Health (ORWH)

301-402-0717 301-435-0971


Sarah Duffy Rosemary D. Higgins, MD

NIDA NICHD

301-443-6504 301-435-7909












52

Amelia Karraker, Ph.D.


301-496-3131

[email protected]

Peer Review Contact



Financial/Grants Management Contact:

Priscilla Grant, J.D. Bryan Clark, MBA

NIMHD NICHD

301-594-8412 301-435-6975


Amy Connolly Judy Fox

NIDA NIAAA

301-827-4457 301-443-4704


Eva Lawson-Lipchin


301-435-2020

[email protected]

PAST FUNDING PROGRAMS THROUGH NATIONAL INSTITUTE OF HEALTH:

58. HEAL Initiative: Antenatal Opioid Exposure Longitudinal Study Consortium

(PL1 Clinical Trial Not Allowed)

https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-19-025.html

FOA: RFA-HD-19-025 Application Due Date: March 29, 2019

Description: The purpose of this funding opportunity announcement is to invite applications from consortia composed of

a Data Coordinating Center and 2 or more Clinical Sites to conduct a multi-center prospective cohort study of infants

exposed to opioids in utero compared to unexposed infants. During a 2-year follow-up period, infants will be assessed

with serial measures including neuroimaging, medical, neurodevelopmental, behavioral, and home, social, and family life

assessments.


governments, and others (i.e. public housing authorities, native American tribes, and faith or community-based

organizations).

Award Information: The number of awards is contingent upon NIH appropriations and the submission of a sufficient

number of meritorious applications. NIH intends to commit $11 million in multi-year funding in FY 2019 to fund 1 award

to a consortium composed of a Data Coordinating Center (DCC) with 2 cores and 2 or more Clinical Sites. This is part of

the NIH HEAL (Helping to End Addiction Long-term) initiative. Application budgets need to reflect the actual needs of

the proposed project. For the Data Coordinating Center, the base budget is limited to $2 million ($500,000/year) in direct

costs for the entire project period of up to 4 years. Clinical Site applicants may request up to $500,000 ($125,000/year) in

direct costs for the entire project period of up to 4 years.







https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-19-025.html

53

The funds available for capitation will rely, in part, on the number of Clinical Sites included in the Consortium and the

base budgets requested. In general, capitation costs are not subject to facilities and administrative costs.

The scope of the proposed project should determine the project period. The maximum project period is 4 years.



Rosemary D. Higgins, M.D

NICHD

301-435-7909

[email protected]

Peer Review Contact

Sherry Dupere, Ph.D.

NICHD

301-496-1485

[email protected]


Bryan S. Clark, M.B.A.

NICHD

301-435-6975

[email protected]

59. HEAL Initiative: Integrated Approach to Pain and Opioid Use in Hemodialysis

Patients: The Hemodialysis Opioid Prescription Effort (HOPE) Consortium -

Clinical Centers (U01 Clinical Trial Required)

https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-18-030.html

FOA: RFA-DK-18-030 Application Due Date: March 27, 2019

Description: The Hemodialysis Opioid Prescription Effort (HOPE) consortium composed of 5 to 7 Clinical Centers

(CCs) and a Scientific and Data Research Center (SDRC) will develop an intervention to simultaneously address the

problem of pain and opioid use in US HD populations by a) initiating multipronged pain treatment tailored individually to

each patient, without opioids, and b) using buprenorphine and other novel agents to reduce dependence on opioids in

affected patients. Analyses will consider comorbid illnesses (such as diabetes and mental health disorders) and social

determinants of health (such as socioeconomic status, social isolation, social support, residential factors, and perception of

racial discrimination) to identify novel risk factors for pain and opioid use in this population. End points will be chronic

opioid prescription rate, prescription drug dose, pain control, patient satisfaction with care, perception of quality of life,

hospitalization rates and mortality. Real time risk factor and outcomes data may be captured using the electronic health

record (EHR), by leveraging and expanding an existing pilot set of more than 200 standardized data elements identified

and prioritized for comprehensive CKD care by the NIDDK CKD eCare Plan Working Group.



organizations).

Award Information: NIDDK intends to commit $4.6 Million in FY 2019 to fund up to 7 awards. Application budgets

are limited to $500,000 direct costs in the first year and should reflect the actual needs of the proposed project. The total

project period may not exceed five years.




54



Paul L Kimmel MD

NIDDK

301-594-1409

[email protected]

Peer Review Contact

Ryan Morris Ph.D.

NIDDK

301-480-1296

[email protected]


Norma Deguzman

NIDDK

301-480-1810

[email protected]

60. HEAL Initiative: Biofabricated 3D Tissue Models of Nociception, Opioid Use

Disorder and Overdose for Drug Screening (UH2/UH3 Clinical Trial Not Allowed)

https://grants.nih.gov/grants/guide/rfa-files/RFA-TR-19-005.html

FOA: RFA-TR-19-005 Application Due Date: February 28, 2019

Description: The purpose of this Funding Opportunity Announcement (FOA) is to support intramural-extramural

collaborations to develop and implement the use of 3D biofabricated tissue models as novel drug screening platforms and

advance pre-clinical discovery and development of non-addictive treatments for nociception, opioid use disorder (OUD)

and/or overdose. In particular, support during the UH2 phase is for the application of 3D biofabrication technologies to

develop novel multicellular tissue constructs for drug screening by using human iPSC-derived cells representing

sensory/pain neurons, brain regions, and other tissues involved in nociception, addiction and/or overdose, including tissue

models of the blood-brain barrier (BBB). Support during the UH3 is for implementation of drug screens using the 3D

tissue models developed during the UH2 phase.



organizations).

Award Information: NCATS intends to fund an estimated of 2-3 awards, corresponding to a total of $1,500,000 for

fiscal year 2019. Future year amounts will depend on annual appropriations. The direct cost for UH2 awards are expected

to be up to $275,000 (exclusive of any contract/consortium F&A) per year. For the UH3 phase, the direct cost amount is

expected to be up to $150,000 per year. The scope of the proposed project should determine the project period. The

proposed project period for the initial development phase (UH2) must not exceed two years. The proposed project period

for the second validation phase (UH3) must not exceed three years.



Dobrila D. Rudnicki, Ph.D.

National Center for Advancing Translational Sciences

301-594-2080

[email protected]

Danilo A. Tagle, Ph.D.

NCATS

301-594-8064

[email protected]




55

Peer Review Contact

Carol Lambert, Ph.D.

NCATS

301-435-0814

[email protected]

Anton Simeonov, Ph.D.

NCATS

301-217-5721

[email protected]

Marc Ferrer, Ph.D.

NCATS

301-217-5722

[email protected]

Michael Oshinsky, Ph.D.

National Institute of Neurological Disorders and Stroke

301-496-9964

[email protected]

Financial/Grants Management Contact Kristin Wegner

NCATS

301-435-0848

[email protected]

Tijuanna Decoster, Ph.D.

NINDS

301-496-9231

[email protected]

61. HEAL Initiative: Tissue Chips to Model Nociception, Addiction, and Overdose

(UG3/UH3 Clinical Trial Not Allowed)


FOA: RFA-TR-19-003 Application Due Date: February 28, 2019

Description: This FOA will provide funding for Investigators to create and test devices that can model the mechanisms or

effects of nociception/pain-relevant signaling, addiction, or opioid use disorders (OUDs), using human tissues in in vitro

microphysiological systems (MPS). Tissue chips, or microphysiological systems, are useful and promising in vitro

human-based screening platforms because they closely mimic in vivo human physiology. Tissue chips have been shown

to be capable of modeling normal and diseased physiology that faithfully recapitulates responses to stressors, treatments

and other perturbations.



organizations).

Award Information: NCATS intends to commit approximately $5 million in FY 2019 to fund 4-6 awards. Funding is

contingent on appropriated amounts. Budget requests are limited to $500,000 direct cost per year. The total project period

may not exceed five years.



Lucie Low, Ph.D.


301-594-7609

[email protected]

Danilo Tagle, Ph.D.


301-594-8064

[email protected]

Fei Wang, Ph.D.

NIAMS

301-594-5055

[email protected]

Seila Selimovic, Ph.D.

NIBIB

301-451-4577

[email protected]









56

Katerina Tsilou, MD

301-496-6287

[email protected]

Nathan M. Appel, Ph.D.

National Institute on Drug Abuse (NIDA)

301-827-5918

[email protected]

Yolanda F. Vallejo, Ph.D.

NIDCR

301-827-4655

[email protected]

Margaret Sutherland, Ph.D.

National Institute of Neurological Disorders and Stroke

NINDS

301-496-5680

[email protected]

Martha S. Lundberg, Ph.D.

NHLBI

301-435-0513

[email protected]

Peer Review Contact

Carol Lambert, Ph.D.

National Center for Advancing Translational Sciences (NCATS)

301-435-0814

[email protected]


Ki-Cha Flash

NCATS

301-435-0846

[email protected]

Erik Edgerton

NIAMS

301-594-7760

[email protected]

Katie Ellis

NIBIB

301-451-4791

[email protected]

Bryan Clark

NICHD

301-435-6975

[email protected]

Pam Fleming

NIDA

301-480-1159

[email protected]

Diana Rutberg, MBA

NIDCR

301-594-4798

[email protected]

Tijuana Decoster

NINDS

301-496-9231

[email protected]

Anthony Agresti

NHLBI

301-827-8014

[email protected]

62. HEAL Initiative: Justice Community Opioid Innovation Network (JCOIN)

Clinical Research Centers (UG1 Clinical Trial Optional)


FOA: RFA-DA-19-025 Application Due Date: February 27, 2019

Description: The intersection of justice and community-based health systems is a critical target for addressing the opioid

crisis. The National Institute on Drug Abuse intends to establish the Justice Community Opioid Innovation Network

(JCOIN) using the cooperative agreement mechanism. The purpose of the network is to establish a national consortium of







57

investigators examining promising interventions and other approaches that can improve the capacity of the justice system

to effectively respond to the opioid epidemic.

The structure of the network must consist of three highly integrated components - (1) Clinical Research Centers (each

center will propose a study to be executed in at least 5 research performance sites), (2) a single, central Coordination and

Translation Center, and (3) a single, central Methodology and Advanced Analytics Resource Center.



organizations).

Award Information: NIDA intends to commit $23.5 million in FY 2019 to fund 8-12 awards. Application budgets are

limited to $1,500,000 per year in direct costs. Facilities and administrative costs requested by consortium participants are

not included in the direct cost limitation. The total project period may not exceed five years.



Tisha Wiley, Ph.D.


301-594-4381

[email protected]


NIAAA

301-451-8507

[email protected]

Peer Review Contact



301-827-5819

[email protected]


Pam Fleming


301-480-1159

[email protected]

Judy Fox

NIAAA

301-443-4704

[email protected]

63. HEAL Initiative: Justice Community Opioid Innovation Network Coordination

and Translation Center


FOA: RFA-DA-19-024 Application Due Date: February 27, 2019

Description: The intersection of justice and community-based health systems is a critical target for addressing the opioid

crisis. The National Institute on Drug Abuse intends to establish the Justice Community Opioid Innovation Network

(JCOIN) using the cooperative agreement mechanism. The purpose of the network is to establish a national consortium of

investigators examining promising interventions and other approaches that can improve the capacity of the justice system

to effectively respond to the opioid epidemic.

The structure of the network shall consist of three highly integrated components - (1) Clinical Research Centers (each

center will propose a study to be executed at least 5 research performance sites), (2) a single, central Coordination and

Translation Center, and (3) a single, central Advanced Analytics and Methodology Resource Center.




58



organizations).

Award Information: NIDA intends to commit $3.5 million in total costs in FY 2019 to fund 1 award. No more than $2.5

million in direct costs may be requested in any single year. The total project period may not exceed five years.



Tisha Wiley, Ph.D.


301-594-4381

[email protected]


NIAAA

301-451-8507

[email protected]

Peer Review Contact



301-827-5819

[email protected]


Pam Fleming


301-480-1159

[email protected]

Judy Fox

NIAAA

301-443-4704

[email protected]

CURRENT FUNDING PROGRAMS THROUGH DOJ’S OFFICE OF JUSTICE

PROGRAMS (OJP):

64. Justice and Mental Health Collaboration Program FY 2019 Competitive Grant

Announcement (BJA)

https://www.bja.gov/funding/JMHCP19.pdf

FOA Number: BJA-2019-15099 Application due: July 15, 2019

Description: The Justice and Mental Health Collaboration Program (JMHCP) supports cross-system collaboration to

improve responses and outcomes for individuals with mental illnesses (MI) or co-occurring mental illness and substance

abuse (CMISA) who come into contact with the justice system. This program supports officer and public safety and

violence reduction through social service and other partnerships that will enhance and increase law enforcement responses

to people with MI and CMISA.

Eligibility: States, units of local government, and federally recognized Indian tribal governments (as determined by the

Secretary of the Interior). BJA will only accept applications that demonstrate that the proposed project will be

administered jointly by an agency with responsibility for criminal or juvenile justice activities and a mental health agency.

Award Information: BJA expects to make up to 57 awards for an estimated total of $23,000,000. See FOA pdf for

specific award amounts and performance periods as they vary based on category applied for.



https://www.bja.gov/funding/JMHCP19.pdf

59


Response Center

[email protected]

65. Enhancing Community Responses to the Opioid Crisis: Serving Our Youngest

Crime Victims (OVC)

https://www.ovc.gov/grants/pdftxt/Opioids_FY-2019-CompetitiveSolicitation.pdf

FOA Number: OVC-2019-15644 Application due: July 11, 2019

Description: The purpose of this solicitation is to address an urgent gap in crime victim services related to the opioid

epidemic and to expand upon existing or establish new programs to provide services to children and youth2 who are

victimized3 as the result of the opioid crisis. OVC anticipates that this solicitation will support service providers in

expanding their current scope and expertise to ensure that children and youth—the most vulnerable victims impacted by

the opioid crisis—are supported as they heal from the impact of crime and substance abuse.

Eligibility: Limited to nonprofit and for-profit organizations (including tribal nonprofit and for-profit organizations),

faith- and community-based organizations, colleges and universities (including tribal institutions of higher education),

public agencies, state agencies, and federally recognized Indian tribal governments, as determined by the Secretary of the

Interior.

Award Information: Number of awards OVC expects to make Approx. 12 to 24 awards (up to 12 non-tribal awards

and up to 12 tribal awards) Estimated maximum dollar amount for each award Up to $750,000 Total amount anticipated

to be awarded under solicitation Up to $18 million (for tribal and non-tribal jurisdictions, combined).


Response Center

[email protected]

PAST FUNDING PROGRAMS THROUGH OJP:

66. Improving Reentry for Adults with Co-occurring Substance Abuse and Mental

Illness (BJA)

https://www.bja.gov/funding/CSAMI19.pdf

FOA Number: BJA-2019-15183 Application due: June 25, 2019

Description: The Improving Reentry for Adults with Co-occurring Substance Abuse and Mental Illness Program

improves provision of services to offenders with co-occurring substance abuse and mental illness (CSAMI) when they

leave incarceration to reenter the community, which in turn will help to reduce recidivism and promote public safety.

Specifically, its goal is to improve access to and delivery of standardized screening and assessment, collaborative

comprehensive case management, and pre- and post-release programming for returning inmates that address criminogenic

risk and needs, including treatment and services that address mental illness and substance abuse. The program prioritizes

coordination among corrections, substance abuse, and mental health treatment providers, as well as correctional health,

and parole or probation services, which enables the development of collaborative comprehensive case plans that address

criminogenic risk, substance abuse, and mental health needs. Past grant cohorts have struggled with standardized CSAMI

screening and assessment, case management, fidelity to evidence-based practices for cognitive behavioral therapy and


https://www.ovc.gov/grants/pdftxt/Opioids_FY-2019-CompetitiveSolicitation.pdf


https://www.bja.gov/funding/CSAMI19.pdf

60

CSAMI, information sharing, and data collection. Within data collection there has been specific issues defining successful

completion, and the development of comprehensive evaluations. Applicants, whether correctional agencies or human

service departments, should consider sustaining the program and system policy changes after the grant period ends.

Eligibility: Limited to states, units of local government, and federally recognized Indian tribes (as determined by the

Secretary of the Interior)

Award Information: BJA expects to make up to 10 awards of up to $1,000,000 each, with an estimated total amount

awarded of up to $10,000,000. BJA expects to make awards for a 48-month period of performance, to begin on October 1,

2019


Response Center

[email protected]

67. Second Chance Act Comprehensive Community-based Adult Reentry Program

(BJA)

https://www.bja.gov/funding/SCAComRe19.pdf


Description: Under this solicitation, BJA is seeking applications to implement or expand on reentry programs that

demonstrate strong partnerships with corrections, parole, probation, law enforcement, and other reentry service providers.

These partnerships should develop comprehensive case management plans that directly address criminogenic risk and

needs, as determined by validated criminogenic risk assessments, and includes delivery or facilitation of services in a

manner consistent with the learning styles and abilities of the participants. This includes ensuring cognitive behavioral

programming is in place pre-release, whether by the lead applicant or a partnering agency.

Participants are expected to be screened, assessed, and identified for program participation pre-release. During the post-

release phase of the reentry program, participants will receive case management services and be connected to evidence-

based programming designed to assist in the transition from prison or jail to the community so that it is safe and

successful. Where feasible, case management services and evidence-based programming should begin during the pre-

release phase.

Eligibility: Eligible applicants are limited to nonprofit organizations (including tribal nonprofit organizations) with a

documented history of providing comprehensive, evidence-based reentry services and federally recognized Indian tribes.

All recipients and subrecipients (including any for-profit organization) must forgo any profit or management fee.

1. Community-based Adult Reentry.

Target Population: The proposed program must commit to serving a minimum of 150 people that

meet the target population requirements of this grant. (See page 8 for information about target

population.)

Award Amount: Awardees will receive up to $1,000,000 each

2. Community-based Adult Reentry with Small or Rural Organizations.

Applicants must demonstrate an annual operating budget of $1,000,000 or less and not be a chapter or

affiliate of a national organization, as defined by having a licensing or other agreement where the

national entity provides financial and/or operational support. Special consideration will be given to

those organizations operating in and serving a rural area of the country.

Target Population: The proposed program must commit to serving a minimum of 75 people that meet

the target population requirements of this grant.


https://www.bja.gov/funding/SCAComRe19.pdf

61

Award Amount: Awardees will receive up to $500,000 each.

Award Information: BJA expects to make 9 awards of up to $1,000,000 each for category 1 and 5 awards of up to

$500,000 for category 2, with an estimated total amount awarded of up to $11,500,000. BJA expects to make all awards

for a 48-month project period, beginning on October 1, 2019.


Response Center

[email protected]

68. Improving Justice and Mental Health Collaboration: Training and Technical

Assistance to Grantees and the Field (BJA)

https://www.bja.gov/funding/JMHCPTTA19.pdf


Description: The primary goal of JMHCP is to facilitate cross-system collaboration among the criminal justice, mental

health, and substance abuse treatment systems to increase access to mental health and other treatment services for

individuals with mental illnesses (MI) or co-occurring mental illness or substance abuse (CMISA). The primary goal of

CBP is to provide comprehensive resources and services to unfunded JMHCP applicants (“customers”) and the field in

general.

1. Justice and Mental Health Collaboration Program Training and Technical Assistance. Objectives:

• Provide comprehensive, responsive, individualized TTA to JMHCP Category 1, 2, and 3 grantees to

meet their objectives, deliverables, and activities.

• Provide TTA to assist JMHCP Category 1 Collaborative County Approaches to Reducing the

Prevalence of Individuals with Serious Mental Illness in Jails grantees to increase and maintain jail

capacity for violent offenders, and develop system wide coordinated approaches to safely reduce the

prevalence of low risk individuals with MI and CMISA in local jails.

• Provide targeted TTA to assist JMHCP Category 2 Strategic Planning for Police and Mental Health

Collaboration grantees to free up law enforcement time to focus on responding to violent crime and to

improve officer and citizen safety during calls for service involving people with MI and CMISA.

• Provide TTA to assist JMHCP Category 3 Implementation and Expansion grantees to increase public

safety and reduce recidivism among high risk people with MI and CMISA.

2. Justice and Mental Health State-based Capacity Building Program. Objectives:

• To develop and provide information and TTA to the field and to support cross-organizational

coordination.

• To increase coordination, tools and resources that build state and local capacity to improve system

responses to, and outcomes for, people with mental illnesses in the justice system.

Eligibility: Eligible applicants are nonprofit organizations (including tribal organizations) and for-profit (commercial and

tribal) organizations, faith-based and community organizations, and institutions of higher education (including tribal

institutions of higher education).

Award Information: BJA expects to make up to two awards with an estimated total amount awarded of up to

$4,340,000. BJA will make two awards, one award in Category 1 and one award in Category 2, each with a twelve month

period of performance. Specific award amounts for each category are identified below.

1. Up to $2,480,000. Project period: 12 months.

2. Up to $1,860,000. Project period: 12 months.



https://www.bja.gov/funding/JMHCPTTA19.pdf

62

Response Center

[email protected]

69. Comprehensive Opioid Abuse Site-based Program (BJA)

https://www.bja.gov/funding/COAP19.pdf


Description: The U.S. Department of Justice (DOJ), Office of Justice Programs (OJP), Bureau of Justice Assistance

(BJA) is seeking applications to plan and implement comprehensive programs in response to the growing opioid

epidemic. This program furthers the Department’s mission by providing resources to support state, local, tribal, and

territorial efforts to reduce violent crime and drug abuse and enhance public safety, while supporting victims.

Eligibility: Eligible applicants are those that meet the following criteria for the three categories:

1. Locally Driven Responses to the Opioid Epidemic – Applicants are limited to units of local government and

federally recognized Indian tribal governments (as determined by the Secretary of the Interior). Jurisdictions

without a county- or local government-based addiction service system may designate the State Administering

Agency (SAA) to serve as the primary applicant and subgrant funds to providers at the county level.

Applicants should ensure they apply under the appropriate subcategory based on the population of the

proposed project area.

a. An urban area or large county with a population greater than 500,000.

b. A suburban area or medium-size county with a population between 100,000 and 500,000.

Subcategory

c. A rural area or small county with a population of fewer than 100,000 or a federally recognized Indian

tribe.

2. Statewide Implementation, Enhancement, and Evaluation Projects – Applicants are limited to the SAA

responsible for directing criminal justice planning or the State Alcohol and Substance Abuse Agency.

3. Harold Rogers Prescription Drug Monitoring Program (PDMP) Implementation and Enhancement Projects –

Applicants are limited to state governments and territories that have a pending or enacted enabling statute or

regulation requiring the submission of controlled substance prescription data to an authorized state agency.

Award Information: BJA expects to make up to 80 awards for varying amounts and performance periods, depending on

the category or subcategory under which the application is awarded (see below). BJA anticipates that over half of these

awards will be funded by the CARA appropriation and the remaining awards will be funded under the Harold Rogers

Prescription Drug Monitoring Program. All performance periods should begin on or after October 1, 2019.

All awards are subject to the availability of appropriated funds and to any modifications or additional requirements that

may be imposed by law.

1. Locally Driven Responses to the Opioid Epidemic. Project period: 36 months. The maximum award amount

available is based on the population of the proposed community to be served as described below.

a. The maximum award available for Category 1a is $1,200,000 for the entire grant period. Subcategory

b. The maximum award available for Category 1b is $900,000 for the entire grant period. Subcategory

c. The maximum award available for Category 1c is $600,000 for the entire grant period

2. Statewide Implementation, Enhancement and Evaluation Projects. Project period: 36 months. Applicants may

apply for Subcategory 2a (projects to be implemented in 3 to 5 sites may request up to $3,000,000; projects to be

implemented in 6 or more sites may request up to $5,000,000) for up to a 36-month period; Subcategory 2b

(projects to be implemented in 3 or more sites may request up to $1,500,000) for up to a 36-month period; or

Subcategory 2c (up to $6,500,000) for up to a 36-month period.


https://www.bja.gov/funding/COAP19.pdf

63

3. Applicants under Category 3 may request a project period of 36 months and an award amount no greater than

$2,000,000

Categories 1 and 2: BJA expects that any award under this solicitation in these categories will be made in the form of a

cooperative agreement. Priority consideration will be given to applicants that:

• Demonstrate the state, or regions within the state, have been disproportionately impacted by the abuse of illicit

opioids and prescription drugs as evidenced, in part, by high rates of primary treatment admissions; high rates of

overdose deaths from heroin and other opioids; and/or a lack of accessibility to treatment providers and facilities and

to emergency medical services.

• Include a research partner that will assist in the identification of the problem, design of the solution, and evaluation

of the proposed initiative.

• Incorporate the use of Overdose Detection Mapping Application Program.

Category 3: BJA expects that any award under this solicitation will be made in the form of a grant. Priority consideration

will be given to applicants that have pending or enacted state legislation that:

• Requires licensed prescribers to register with the PDMP.

• Requires prescribers to query the PDMP before prescribing drugs in Schedules II, III, and IV.

• Allows the PDMP to proactively analyze their data.

• Requires interstate data sharing of PDMP data.

• Allows law enforcement access to the PDMP based on an open investigation.

• Allows unsolicited reports to be sent to regulatory/licensing boards and law enforcement.


Response Center

[email protected]

800-851-3420

70. Juvenile Drug Treatment Court Program (OJJDP)

https://www.ojjdp.gov/grants/solicitations/FY2019/JDTC.pdf

FOA Number: OJJDP-2019-15032 Application due: May 30, 2019

Description: The Juvenile Drug Treatment Court Program builds the capacity of states, state and local courts, units of

local government, and federally recognized tribal governments to enhance existing drug courts or implement new juvenile

drug treatment courts (JDTCs) for individuals with substance abuse problems or co-occurring mental health disorders,

including histories of trauma. OJJDP expects successful applicants to develop and implement a sustainability plan during

the grant period to continue operation of the drug court when the grant ends.

1. Juvenile Drug Treatment Court Planning: This program will support jurisdictions that have identified a need

to establish a JDTC. Funding under this program will support a 24-month planning process that will educate

the JDTC team about the basic components of a JDTC and develop a program that integrates court and

treatment functions.

2. Juvenile Drug Treatment Court Enhancement: The goal of this category is to enhance the capacity of JDTCs

and ultimately improve the outcome for the youth involved in the JDTC. Applicants may consider

enhancements on one or more of the following key components of a JDTC, but are not limited to these.

JDTCs should propose enhancements according to their greatest areas of need for improvement.

Eligibility: Government Entities. Eligible App Subcategories: Courts, Local, State, U.S. Territories

Award Information: OJJDP expects to make 10 awards for a total of $3,250,000.

1. Up to 5 awards of $250,000 each, period of performance is 2 years.


https://www.ojjdp.gov/grants/solicitations/FY2019/JDTC.pdf

64

2. Up to 5 awards of $400,000 each, period of performance is 3 years.


Response Center

[email protected]

800-851-3420

71. Family Drug Court Program (OJJDP)

https://www.ojjdp.gov/grants/solicitations/FY2019/FDCP.pdf


Description: The U.S. Department of Justice (DOJ), Office of Justice Programs (OJP), Office of Juvenile Justice and

Delinquency Prevention (OJJDP) is seeking applications for funding under the fiscal year (FY) 2019 Family Drug Courts

Program. This program furthers the Department’s mission by supporting states and communities as they develop and

implement effective and coordinated substance abuse intervention programs.

This solicitation incorporates the OJP Grant Application Resource Guide by reference. The OJP Grant Application

Resource Guide provides guidance to applicants on how to prepare and submit applications for funding to OJP. If this

solicitation expressly modifies any provision in the OJP Grant Application Resource Guide, the applicant is to follow the

guidelines in this solicitation as to that provision. There are three categories

1. To enhance and/or expand existing family drug courts to provide substance-abusing parents with treatment

and accountability by offering access to recovery services that will ultimately protect children; reunite

families, when safe to do so; and, expedite permanency.

2. Serving Veterans Through Family Drug Courts: It is estimated that between 30-35% of veterans are affected

by overlapping trauma and substance abuse disorders. Secondary trauma affecting veteran families has been

documented, along with higher frequency of family stress and violence.10 Substance abuse disorders, as well

as co-occurring mental health disorders such as post-traumatic stress, brain injuries, and other consequences

of military service and/or deployment, may result in some of these families being referred to child protective

services or family violence caseloads in response to incidents within the family. Therefore, identifying and

addressing parental distress are critical to preventing and intervening in child maltreatment in veteran

families. A collaborative approach among child and

3. Establishing New Family Drug Courts: The goal of programs funded under Category 3 is to implement new

family drug courts to provide substance-abusing parents with treatment and accountability by offering access

to recovery services that will ultimately protect children; reunite families, when safe to do so; and expedite

permanency. Priority will be given to applicants that include a plan to develop and implement a specialized

track of services for military veteran parents in their programs.

Eligibility: Eligible applicants are limited to states, territories, State courts, local courts, units of local government, and

federally recognized Indian tribal governments (as determined by the Secretary of the Interior) acting on behalf of a single

jurisdiction drug court. Faith and community-based organizations, nonprofit organizations and for-profit organizations

(including tribal nonprofit and for-profit organizations), and institutions of higher education

This solicitation is composed of three grant categories. Applicants must clearly designate the category for which they are

applying. Category 1: Enhancing Family Drug Courts and Category 2: Serving Veterans Through Family Drug Courts are

available to jurisdictions with a fully operational family drug court. Courts applying for funding under category 1 or 2

must be fully operational for at least 1 year, as funding is intended to enhance services of existing family drug courts.

Category 3: Establishing New Family Drug Courts grants are available to jurisdictions that are ready to implement a new

family drug court. These grants are for jurisdictions where either no family drug court currently exists or a family drug


https://www.ojjdp.gov/grants/solicitations/FY2019/FDCP.pdf

65

court has been operational for less than 1 year. Jurisdictions may already have other types of drug or treatment courts

(such as adult drug or mental health courts).

All Categories. All recipients and subrecipients (including any for-profit organization) must forgo any profit or

management fee.

OJJDP will consider applications under which two or more entities would carry out the federal award; however, only one

entity may be the applicant. Any others must be proposed as subrecipients (subgrantees). The applicant must be the entity

that would have primary responsibility for carrying out the award, including administering the funding and managing the

entire program. Under this solicitation, only one application by any particular applicant entity will be considered. An

entity may, however, be proposed as a subrecipient (subgrantee) in more than one application. For additional information

on subawards, see the OJP Grant Application Resource Guide.

Award Information: OJJDP expects to make a maximum of 14 awards. Total amount anticipated to be awarded under

solicitation: $9,000,000 million for a period of performance of 3 years.

1. OJJDP expects to make eight awards of up to $750,000 each.

2. OJJDP expects to make three awards of up to $350,000 each.

3. OJJDP expects to make three awards of up to $650,000 each.


Response Center

[email protected]

800-851-3420

72. Office Anti-Heroin Task Force (AHTF) Program Application Guide (COPS)

https://cops.usdoj.gov/pdf/2019AwardDocs/ahtf/FY19_AHTF_App_Guide.pdf

FOA Number: : COPS-AHTF-APPLICATION-2019 Application due: May 28, 2019

Description: AHTF funds awarded in this program shall be used for investigative purposes to locate or investigate illicit

activities, including activities related to the distribution of heroin, fentanyl, or carfentanil or the unlawful distribution of

prescription opioids. AHTF will be open to state law enforcement agencies with multijurisdictional reach and an

interdisciplinary team (e.g. task force) structures. These state law enforcement agencies must have primary law

enforcement authority over heroin and other opioids seizures.

Eligibility: Open to state law enforcement agencies in states with high per capita rates of primary treatment admissions,

for the purpose of locating or investigating illicit activities, through statewide collaboration, relating to the distribution of

heroin, fentanyl, or carfentanil or the unlawful distribution of prescription opioids. These state law enforcement agencies

must have primary authority over state seizures of heroin and other opioids.

Award Information: AHTF provides funding for 24 months directly to state law enforcement agencies with high rates of

primary treatment admissions for heroin and other opioids. The COPS Office anticipates making approximately 10 2019

AHTF awards for a total of approximately $32,000,000. Funding requests under this program will be capped at

$3,000,000 per award.


Response Center

[email protected]

800-421-6770


https://cops.usdoj.gov/pdf/2019AwardDocs/ahtf/FY19_AHTF_App_Guide.pdf

66

73. Tribal Justice CTAS Training and Technical Assistance Solicitation (BJA)

https://www.bja.gov/funding/TribalJusticeTTA19.pdf

FOA Number: BJA-2019-15929 Application due: May 14, 2019

Description: The TTA will provide tribal jurisdictions with assistance to: (1) develop strategies to address crimes relating

to substance abuse and other controlled substances; and (2) implement and enhance tribal justice systems including tribal

law enforcement, courts, prosecution, and pretrial; (3) conduct comprehensive justice system-wide strategic planning and

develop written justice systemwide strategic plans; (4) address violent crime in tribal communities; (5) address the tribal

justice needs of Alaska Native Villages; and (6) develop and foster intergovernmental collaboration among tribal-federal-

state-local governments in order to improve public safety and victims’ services. The main focus of the TTA will be with

tribes who receive funding under CTAS Purpose Areas 2 (Strategic Planning), 3 (Tribal Justice Systems), and 10 (Violent

Crime).

Eligibility: For-profit organizations, nonprofit organizations (including tribal nonprofit or for-profit organizations), faith-

based and community organizations, institutions of higher education (including tribal institutions of higher education),

and consortiums (including tribal consortiums) with demonstrated national-scope and onsite experience working with

American Indian and Alaska Native tribes.

Award Information: BJA expects to make up to 7 awards of up to $300,000 - $800,000 each (see pages 11-19 for

details) with an estimated total amount awarded of up to $5,025,000 for an 18 - 24-month project period, beginning on

October 1, 2019.


Response Center

[email protected]

800-851-3420

74. Opioid Affected Youth Initiative (OJJDP)

https://www.ojjdp.gov/grants/solicitations/FY2019/Opioid.pdf



Delinquency Prevention is seeking applications for funding under the fiscal year (FY) 2019 Opioid Affected Youth

Initiative. This Initiative supports states, local communities, and tribal jurisdictions in their efforts to develop and

implement effective programs for children, youth, and at-risk juveniles and their families who have been impacted by the

opioid crisis and drug addiction.

This solicitation incorporates the OJP Grant Application Resource Guide by reference. The OJP Grant Application

Resource Guide provides guidance to applicants on how to prepare and submit applications for funding to OJP. If this

solicitation expressly modifies any provision in the OJP Grant Application Resource Guide, the applicant is to follow the

guidelines in this solicitation as to that provision.

Eligibility: Eligible applicants are limited to states (including territories), units of local government, and federally

recognized tribal governments as determined by the Secretary of the Interior.

All recipients and subrecipients (including any for-profit organization) must forgo any profit or management fee. OJJDP

will consider applications under which two or more entities would carry out the federal award; however, only one entity




https://www.ojjdp.gov/grants/solicitations/FY2019/Opioid.pdf

67

may be the applicant. Any others must be proposed as subrecipients (subgrantees). The applicant must be the entity that

would have primary responsibility for carrying out the award, including administering the funding and managing the

entire program.

Under this solicitation, only one application by any particular applicant entity will be considered. An entity may, however,

be proposed as a subrecipient (subgrantee) in more than one application. For additional information on subawards, see the

OJP Grant Application Resource 2 OJJDP-2019-15035 Guide.

Award Information: OJJDP expects to make up to 7 awards of up to $1,000,000 each for a total of $7,000,000. The

period of performance starting October 1, 2019 and continuing for 3 years.




Response Center

[email protected]

800-851-3420

75. Drug Court Training and Technical Assistance Program (OJJDP)


Description: This program will fund training and technical assistance (TTA) to states, state and local courts, units of local

government, and tribal governments that will build their capacity to develop, maintain, and enhance drug courts for

juveniles and parents/guardians with substance abuse problems or co-occurring mental health disorders, specifically those

related to opioid abuse. This solicitation has two categories—Category 1: Juvenile Drug Treatment Courts Training and

Technical Assistance Program and Category 2: Family Drug Courts Training and Technical Assistance Program.

1. Category 1: Juvenile Drug Treatment Courts TTA Program The goal of the Juvenile Drug Treatment

Courts TTA Program: is to build the capacity and effectiveness of juvenile drug treatment courts. The

successful applicant should have substantial experience in assessing TTA needs, effectively communicating

and collaborating with drug courts, providing peer-to-peer training, providing individualized technical

assistance, and conducting post-training follow-up and evaluations. Training and technical assistance should

be targeted to all OJJDP-funded juvenile drug treatment courts and reach as many juvenile drug treatment

courts as possible.

2. Category 2: Family Drug Courts TTA Program The goal of the Family Drug Courts TTA Program: is

to help family drug court practitioners develop, maintain, and enhance family drug courts. The successful

applicant should have substantial experience in assessing training needs, effectively communicating and

collaborating with drug courts, providing peer-to-peer training, and conducting post-training follow-up and

evaluations. It is expected that the successful applicant will develop a TTA strategy and prioritization

approach that includes both OJJDP-funded family drug courts and other family drug courts with identified

needs. 9

Eligibility: Eligible applicants are limited to nonprofit organizations1 and for-profit organizations (including tribal

nonprofit and for-profit organizations) and institutions of higher education (including tribal institutions of higher

education). All recipients and subrecipients (including any for-profit organization) must forgo any profit or management

fee.

OJJDP welcomes applications under which two or more entities would carry out the federal award; however, only one

entity may be the applicant. Any others must be proposed as subrecipients (subgrantees).2 The applicant must be the


68

entity that would have primary responsibility for carrying out the award, including administering the funding and

managing the entire program. Under this solicitation, only one application by any particular applicant entity will be

considered. An entity may, however, be proposed as a subrecipient (subgrantee) in more than one application.

Award Information: OJJDP expects to make up to two awards with an estimated total amount awarded of up to

$8,000,000. OJJDP expects to make awards for a 36-month period of performance, to begin on October 1, 2019.

1. Under Category 1 (Juvenile Drug Treatment Courts TTA), OJJDP expects to make one award of up to

$3,500,000.

2. Under Category 2 (Family Drug Courts TTA), OJJDP expects to make one award of up to $4,500,000.

OJJDP-2019-15023 13 All awards are subject to the availability of appropriated funds and to any

modifications or additional requirements that may be imposed by law.


Response Center

[email protected]

800-851-3420

76. Research and Evaluation on Drugs and Crime (NIJ)

https://nij.gov/funding/Documents/solicitations/NIJ-2019-15444.pdf

FOA Number: BJA-2019-15269 Application due: May 6, 2019

Description: This program furthers DOJ’s mission to combat the Nation's opioid epidemic, support prosecutors in their

efforts, and reduce violent and other drug-related crime through research that promotes effective law enforcement, court,

and corrections responses to illegal drug markets (including diversion of legal drugs). The research focus of this

solicitation is criminal investigation, prosecution, drug intelligence, and community surveillance relevant to narcotics law

enforcement, forensic science, and/or medicolegal death investigation. DOJ has identified the FY 2019 solicitation drug

priorities as: 1) fentanyl and its illicit analogues; 2) methamphetamine; and 3) illegal marijuana markets.

Eligibility: In general, NIJ is authorized to make grants to, or enter into contracts or cooperative agreements with, States

(including territories), units of local government, federally recognized Indian tribal governments that perform law

enforcement functions (as determined by the Secretary of the Interior), nonprofit and for-profit organizations (including

tribal nonprofit and for-profit organizations), institutions of higher education (including tribal institutions of higher

education), and certain qualified individuals.

NIJ welcomes applications under which two or more entities would carry out the federal award; however, only one entity

may be the applicant. Any others must be proposed as subrecipients (subgrantees) . The applicant must be the entity that

would have primary responsibility for carrying out the award, including administering funding, managing the entire

project, and monitoring and appropriately managing any subawards (“subgrants”).

Under this solicitation, any particular applicant entity may submit more than one application, as long as each application

proposes a different project in response to the solicitation. Also, an entity may be proposed as a subrecipient (subgrantee)

in more than one application.

NIJ may elect to fund applications submitted under this FY 2019 solicitation in future fiscal years, dependent on, among

other considerations, the merit of the applications and on the availability of appropriations.

Award Information: NIJ anticipates at least $3 million will be available to fund five or more grants across the three drug

priorities. Awards will normally not exceed a three-year period of performance, and applications proposing shorter

timelines are preferred.


https://nij.gov/funding/Documents/solicitations/NIJ-2019-15444.pdf

69


Response Center

[email protected]

800-851-3420

77. Residential Substance Abuse Treatment (RSAT) for State Prisoners Program

https://www.bja.gov/funding/rsat19.pdf

FOA Number: BJA-2019-15269 Application due: April 30, 2019

Description: The U.S. Department of Justice (DOJ), Office of Justice Programs (OJP), Bureau of Justice Assistance

(BJA) is seeking applications for funding under the Residential Substance Abuse Treatment for State Prisoners Program.

This program furthers the Department’s mission by assisting state, local, and tribal efforts to break the cycle of drug

addiction and violence by reducing the demand for, use, and trafficking of illegal drugs.

This solicitation incorporates the OJP Grant Application Resource Guide by reference. It provides guidance to applicants

on how to prepare and submit applications for funding to OJP. If this solicitation expressly modifies any provision in the

OJP Grant Application Resource Guide, the applicant is to follow the guidelines in this solicitation as to that provision.

This solicitation expressly modifies the OJP Grant Application Resource Guide by not incorporating the “Limitation on

Use of Award Funds for Employee Compensation; Waiver” provisions in the “Financial Information” section of the OJP

Grant Application Resource Guide.

Eligibility: Eligible applicants are limited to states. For purposes of this solicitation, states are defined as all U.S. states,

the District of Columbia, the Commonwealth of Puerto Rico, the U.S. Virgin Islands, American Samoa, Guam, and the

Northern Mariana Islands. By statute (34 U.S.C § 10421), BJA must award RSAT grants to the state office (see

www.ojp.usdoj.gov/saa/index.htm for Administering Agencies list) designated to administer the Byrne Justice Assistance

Grant Program. The state office may award subgrants1 to state agencies and units of local government, including

federally-recognized Indian tribal governments that perform law enforcement functions (as determined by the Secretary of

the Interior).

In order to be eligible to receive an award under this solicitation, the application must demonstrate that a minimum of 25

percent of the total costs of each project under an award will be funded with non-federal funds. The federal share of an

RSAT award may not exceed 75 percent of the total costs of the projects described in the application. 34 U.S.C. 10424.

Award Information: Each participating state is allocated a base award of 0.4 percent of the total funds available for

RSAT. BJA will allocate a portion of the total remaining funds to each participating state in the same percentage that the

state’s prison population represents relative to the total prison population of all states. BJA estimates that it will make up

to 56 awards for an estimated total of $12,000,000 for a 48-month period of performance, beginning on October 1, 2019.


Response Center

[email protected]

800-518-4726

78. Mentoring Opportunities for Youth Initiative: Category 1-5: (OJJDP)

https://www.ojjdp.gov/grants/solicitations/FY2019/MentOpps.pdf


https://www.bja.gov/funding/rsat19.pdf


https://www.ojjdp.gov/grants/solicitations/FY2019/MentOpps.pdf

70

Grants.gov Number: OJJDP-2019-15004 Application due: April 22, 2019


Delinquency Prevention (OJJDP) is seeking applications for funding under the fiscal year (FY) 2019 Mentoring

Opportunities for Youth Initiative. This program furthers the Department’s mission by supporting mentoring programs to

reduce juvenile delinquency, drug abuse (especially opioid abuse), victimization, and problem and high-risk behaviors

such as truancy.

Eligibility: All recipients and subrecipients (including any for-profit organization) must forgo any profit or management

fee. OJJDP may elect to fund applications submitted under this FY 2019 solicitation in future fiscal years, dependent on,

among others considerations, the merit of the applications and the availability of appropriations.

1. National Mentoring Programs.

a. Eligible applicants are limited to national organizations, defined as organizations that have active chapters

or subawardees in at least 45 states. Applicants must include a list of active chapters or subawardees and

the states where they are located as an attachment to their application. For the purposes of this

solicitation, 2 or more independent organizations that form a collaborative to meet the 45-state

requirement do not satisfy OJJDP’s definition of a national organization. The organization’s national

headquarters must submit the application. OJJDP encourages applicants to minimize their administrative

costs in an effort to subaward at least 90 percent of this award to active chapters or subrecipients, located

in at least 38 states, while at the same time allowing for effective subrecipient oversight.

2. Multistate Mentoring Programs.

a. Eligible applicants are limited to multistate organizations, defined as organizations that have operated an

established mentoring program for at least 3 years and have active chapters or subawardees in at least 5

states but fewer than 45 states. Applicants must include a list of active chapters or subawardees and the

states where they are located as an attachment to their application. For the purposes of this solicitation,

two or more independent organizations that form a collaborative to meet the five-state requirement do not

satisfy OJJDP’s definition of a multistate organization. The organization’s headquarters must submit the

application.

3. Mentoring Programs for Youth Involved in the Juvenile Justice System.

a. Eligible applicants are limited to private organizations (nonprofit organizations2 and for-profit

organizations, including tribal nonprofit and for-profit organizations, and faith-based organizations). Joint

applications from two or more eligible applicants are welcome; however, one applicant must be clearly

indicated as the primary applicant (for correspondence, award, and management purposes) and the others

indicated as coapplicants. To be eligible in Category 3, applicants must at the time of application: • Have

operated an established mentoring program for at least 1 year. • Have a demonstrated partnership (via a

memorandum of understanding) with a public agency legally responsible for handling juvenile crime and

delinquency in a state, tribe, city, or county (hereafter referred to as juvenile justice agency).

4. Mentoring Strategies for Youth Impacted by Opioids

a. Eligible applicants are limited to private organizations (nonprofit organizations and for-profit

organizations, including tribal nonprofit and for-profit organizations, and faith-based organizations). Joint

applications from two or more eligible applicants are welcome; however, one applicant must be clearly

indicated as the primary applicant (for correspondence, award, and management purposes) and the others

indicated as coapplicants. To be eligible in Category 4, applicants must at the time of application: • Have

operated an established mentoring program for at least 1 year. • Have a demonstrated partnership (via a

memorandum of understanding) with a public or private substance abuse treatment agency.

5. Statewide and Regional Mentoring Initiative for Youth Impacted by Opioids

a. Eligible applicants are limited to national organizations (as defined in Category 1), states (including

territories), and federally recognized tribal governments as determined by the Secretary of the Interior.

Eligible applicants must provide mentoring services to youth who are 17 years old or younger at the time

of admission to the program. An organization that applies for funding in Category 1 may also be eligible

to apply for Category 5, but is ineligible to apply for funds in Categories 2, 3, and 4. An organization that

applies for funding in Category 2 may also apply to receive funds in Categories 3 and 4.

71

Award Information: When making final award decisions, OJJDP will consider geographic coverage; the provision of

services to specific populations, including rural and tribal communities; and the peer review results. OJJDP expects to

award grant funds under this solicitation no later than September 30, 2019.



1. An application may be for a period of performance of as long as 3 years. The requested award amount should

cover the entire proposed period of performance and be based on the allowable costs associated with the

program, including but not limited to the costs of planning and implementing the proposed program. OJJDP

encourages applicants to minimize their administrative costs in an effort to subaward at least 90 percent of

this award to active chapters or subrecipients, located in at least 38 states, while at the same time allowing for

effective subrecipient oversight. Based on the availability of funding, OJJDP may request that an applicant

selected for funding reduce their proposed budget. OJJDP plans to make up to five awards in this category.

2. An application may be for a period of performance of as long as 3 years. Applicants that meet the minimum

requirement of having active chapters or subawardees in at least five states may request as much as $2

million, and those applicants that demonstrate the broadest reach (as detailed above) may request as much as

$4 million. See the priority considerations for Category 2 listed on pages 7–8. The requested award amount

should cover the entire proposed period of performance and be based on the cost of implementing the

proposed program. Based on the availability of funding, OJJDP may request that an applicant selected for

funding reduce their proposed budget. OJJDP plans to make up to twelve awards in this category.

3. An applicant may request as much as $500,000 for a period of performance of as long as 3 years. The

requested award amount should cover the entire proposed period of performance and be based on the cost of

implementing the proposed program. Based on the availability of funding, OJJDP may request that an

applicant selected for funding reduce their proposed budget. OJJDP plans to make up to nine awards in this

category.

4. An applicant may request as much as $500,000 for a period of performance of as long as 3 years. The



applicant selected for funding reduce their proposed budget. OJJDP plans to make up to nine awards in this

category.

5. An applicant may request as much as $1,250,000 for a period of performance of as long as 3 years. The



applicant selected for funding reduce their proposed budget. OJJDP plans to make up to six awards in this

category.


Response Center

[email protected]

800-851-3420

79. Innovative Prosecution Solutions for Combating Violent Crime (BJA)

https://www.bja.gov/funding/IPS19.pdf


Description: The purpose of this program is to provide state, local, and tribal prosecutors with information, resources, and

training and technical assistance (TTA) to develop effective strategies and programs to address and prosecute individuals

who commit violent crime. Prosecutors are leaders within the criminal justice system and possess an enormous


https://www.bja.gov/funding/IPS19.pdf

72

responsibility within the criminal justice system. Accordingly, they are well-positioned to bring the police, community,

and local agencies together to combat violent crime in their jurisdictions.

Eligibility: Eligible applicants are limited to state and local prosecutorial agencies, federally recognized Indian tribal

governments that perform prosecution functions (as determined by the Secretary of the Interior), or tribal consortia

consisting of two or more federally recognized Indian tribes (including tribal consortia operated as nonprofit

organizations) acting as a fiscal agent for one or more prosecutor agencies.

Award Information: BJA estimates that it will make up to six awards of up to $360,000 each for an estimated total of

$2,160,000 for a 24-month period of performance, to begin on October 1, 2019. BJA may, in certain cases, provide

additional funding in future years to awards made under this solicitation, through continuation awards. In making

decisions regarding continuation awards, OJP will consider, among other factors, the availability of appropriations, when

the program or project was last competed, OJP’s strategic priorities, and OJP’s assessment of both the management of the

award (for example, timeliness and quality of progress reports), and the progress of the work funded under the award.


Response Center

[email protected]

800-518-4726

80. Adult Drug Court Discretionary Grant Program (BJA)

https://www.bja.gov/Funding/ADC19.pdf


Description: The ADC Discretionary Grant Program provides financial and technical assistance to states, state courts,

local courts, units of local government, and federally recognized Indian tribal governments to develop and implement

drug courts and veterans treatment courts. BJA is accepting applications for FY 2019 grants to either establish new drug

courts or enhance existing drug court programs using evidence-based principles and practices. BJA also supports courts

that integrate the National Association of Drug Court Professionals (NADCP) Adult Drug Court Best Practice Standards

(drug court standards) into existing drug court services

Eligibility: For Category 1: Implementation and Category 2: Enhancement, eligible applicants are states, territories, state

and local courts, counties, units of local government, and federally recognized Indian tribal governments (as determined

by the Secretary of the Interior) on behalf of a single jurisdiction drug court.

For Category 3: Statewide, eligible applicants are state agencies such as the State Administering Agency (SAA), the

Administrative Office of the Courts, and the State Substance Abuse Agency. State agencies can also include state criminal

justice agencies and other state agencies involved with the provision of substance abuse and/or mental illness services, or

related services, to criminal substance abusers.

Award Information: BJA expects to make up to 85 awards. For category 1: $500,000 each for up to 4 years, for

Category 2: $500,000 each for up to 3 years, and for Category 3: per applicant for Subcategories A and B: $2,000,000 for

state-based coordination of services at a maximum of $500,000 per applicant under subcategory A for 3 years and a

maximum of $1,500,000 is available per applicant under subcategory B for 4 years.


Response Center

[email protected]

800-518-4726


https://www.bja.gov/Funding/ADC19.pdf


73

81. Adult Drug Court and Veterans Treatment Court Planning, Training, Technical

Assistance and Resource Center Initiative (BJA)

https://www.bja.gov/funding/ADCVTCTTA19.pdf


Description: This solicitation seeks providers to support both Adult Drug Court (ADC) and Veterans Treatment Court

(VTC) Program grantees. ADC TTA providers for all categories in this solicitation are expected to participate in an ADC

TTA collaborative to work together to assist states, veterans, tribes, and local justice system officials and treatment

professionals to implement evidence-based drug court practices.

1) Adult Drug Court Planning Initiative

2) Adult Drug Court Training Initiative and the National Drug Court Resource Policy, and Evidence-based

practice center

3) Adult Drug Court Site-specific technical assistance program

4) Adult Drug Court State-based technical assistance program

5) Veterans Treatment Court Site-specific Training and Technical Assistance

6) Tribal Healing to Wellness Drug Court Site-specific Training and Technical Assistance

Eligibility: Eligible applicants are limited to for-profit (commercial) organizations, nonprofit organizations (including

tribal organizations), faith-based and community organizations, and institutions of higher education (including tribal

institutions of higher education) with demonstrated expertise in assisting communities to develop, implement, and

enhance drug courts.

The applicant must be the entity that would have primary responsibility for carrying out the award, including

administering the funding and managing the entire project. An entity may also be proposed as a subrecipient (subgrantee)

in more than one application.

Award Information: BJA expects to make up to 7 awards of up to $20,700,000.


Response Center

[email protected]

800-518-4726

82. U.S. Department of Justice Coordinated Tribal Assistance Solicitation

https://www.justice.gov/tribal/page/file/1114606/download

Application due: March 12, 2019

Description: To provide comprehensive training and technical assistance to tribes in the areas of alcohol and substance

abuse related crime, tribal courts and tribal justice systems, Alaska Native justice systems, addressing violent crime and

supporting prosecutors in tribal communities.

Eligibility: Non-Government Organizations. Eligible App Subcategories: For-Profit, Non-Profit. Only federally

recognized Indian tribes, as determined by the Secretary of the Interior may apply

https://www.bja.gov/funding/ADCVTCTTA19.pdf


https://www.justice.gov/tribal/page/file/1114606/download

74

Award Information: BJA expects to issue 5 awards of $150,000 totaling $750,000 over 3 years for Comprehensive tribal

justice systems strategic planning. For Tribal Justice Systems, $250,000 to 750,000 per award totaling $16.8 million total

over 3 years. For Tribal Justice Systems infrastructure program $1-4 million per award over three years totaling $7.5

million.


Technical Application Assistance

[email protected]
